US20150182697A1 - Pump, motor and assembly for beneficial agent delivery - Google Patents
Pump, motor and assembly for beneficial agent delivery Download PDFInfo
- Publication number
- US20150182697A1 US20150182697A1 US14/586,927 US201414586927A US2015182697A1 US 20150182697 A1 US20150182697 A1 US 20150182697A1 US 201414586927 A US201414586927 A US 201414586927A US 2015182697 A1 US2015182697 A1 US 2015182697A1
- Authority
- US
- United States
- Prior art keywords
- pump
- processor
- cassette
- drive component
- coupled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009286 beneficial effect Effects 0.000 title claims abstract description 82
- 239000012530 fluid Substances 0.000 claims abstract description 175
- 230000004913 activation Effects 0.000 claims abstract description 5
- 238000005086 pumping Methods 0.000 claims description 49
- 238000004891 communication Methods 0.000 claims description 29
- 230000015654 memory Effects 0.000 claims description 17
- 230000005055 memory storage Effects 0.000 claims description 9
- 230000000007 visual effect Effects 0.000 claims description 9
- IVTMXOXVAHXCHI-YXLMWLKOSA-N (2s)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid;(2s)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1.NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 IVTMXOXVAHXCHI-YXLMWLKOSA-N 0.000 claims description 7
- 230000005236 sound signal Effects 0.000 claims description 6
- 235000014676 Phragmites communis Nutrition 0.000 claims description 5
- 239000003990 capacitor Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 description 60
- 238000000034 method Methods 0.000 description 50
- 230000002572 peristaltic effect Effects 0.000 description 44
- 238000010586 diagram Methods 0.000 description 26
- 230000033001 locomotion Effects 0.000 description 19
- 230000007246 mechanism Effects 0.000 description 15
- 239000003814 drug Substances 0.000 description 14
- 238000001514 detection method Methods 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 229910010293 ceramic material Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229940124597 therapeutic agent Drugs 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 230000002093 peripheral effect Effects 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 239000004642 Polyimide Substances 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 230000006266 hibernation Effects 0.000 description 4
- 229920001721 polyimide Polymers 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 235000010649 Lupinus albus Nutrition 0.000 description 3
- 240000000894 Lupinus albus Species 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000004973 liquid crystal related substance Substances 0.000 description 3
- 238000005461 lubrication Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 239000003124 biologic agent Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229940125693 central nervous system agent Drugs 0.000 description 2
- 239000003576 central nervous system agent Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920006267 polyester film Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- 229910000755 6061-T6 aluminium alloy Inorganic materials 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 229940123736 Decarboxylase inhibitor Drugs 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 229920004943 Delrin® Polymers 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 208000006440 Open Bite Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- GPVWCGHDIGTNCE-UHFFFAOYSA-N [Fe](=S)=S.[Li] Chemical compound [Fe](=S)=S.[Li] GPVWCGHDIGTNCE-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000002048 anodisation reaction Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 229960004205 carbidopa Drugs 0.000 description 1
- TZFNLOMSOLWIDK-JTQLQIEISA-N carbidopa (anhydrous) Chemical compound NN[C@@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-JTQLQIEISA-N 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000003954 decarboxylase inhibitor Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960004502 levodopa Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000011224 oxide ceramic Substances 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 230000034958 pharyngeal pumping Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14228—Pumping with an aspiration and an expulsion action with linear peristaltic action, i.e. comprising at least three pressurising members or a helical member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/08—Machines, pumps, or pumping installations having flexible working members having tubular flexible members
- F04B43/082—Machines, pumps, or pumping installations having flexible working members having tubular flexible members the tubular flexible member being pressed against a wall by a number of elements, each having an alternating movement in a direction perpendicular to the axes of the tubular member and each having its own driving mechanism
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/12—Machines, pumps, or pumping installations having flexible working members having peristaltic action
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B43/00—Machines, pumps, or pumping installations having flexible working members
- F04B43/12—Machines, pumps, or pumping installations having flexible working members having peristaltic action
- F04B43/1223—Machines, pumps, or pumping installations having flexible working members having peristaltic action the actuating elements, e.g. rollers, moving in a straight line during squeezing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M2005/16863—Occlusion detection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M2005/16863—Occlusion detection
- A61M2005/16868—Downstream occlusion sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M2005/16863—Occlusion detection
- A61M2005/16872—Upstream occlusion sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/12—General characteristics of the apparatus with interchangeable cassettes forming partially or totally the fluid circuit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/14—Detection of the presence or absence of a tube, a connector or a container in an apparatus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/16—General characteristics of the apparatus with back-up system in case of failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/60—General characteristics of the apparatus with identification means
- A61M2205/6054—Magnetic identification systems
Abstract
Description
- This application claims priority to U.S. Provisional Patent Application Nos. 61/922,709, filed Dec. 31, 2013; and 62/054,134, filed Sep. 23, 2014; each of which is incorporated by reference herein in its entirety.
- 1. Field of the Disclosed Subject Matter
- The disclosed subject matter is generally related to devices, systems and methods for controlling and delivering fluids, for example for delivery of a beneficial agent to a user.
- 2. Description of Related Art
- A variety of fluid transport devices and systems have been developed for controlling and delivering beneficial agents in fluid form. Such fluid flow systems can include 1) volumetric-based aspiration flow systems using positive displacement pumps, and 2) vacuum-based aspiration systems using a vacuum source. For example, volumetric aspiration systems include peristaltic pumps for the delivery of therapeutic agents to a user. Various forms of peristaltic pumps are known, such as using rotating rollers to press against a flexible tubing to induce flow therethrough. Cassette systems or other reservoir configurations can be coupled with the pump device to provide a source of beneficial agent fluid via the flexible tubing.
- Such devices and systems are particularly beneficial as portable infusion pumps capable of being worn or carried by the user. However, there remains a need for improvement of such devices and systems. Such improvements include, among other things, improved energy consumption and battery life, improved pump efficiency and control, improved comfort and ergonomics, and improved cassette configuration for more complete access to the reservoir contents.
- The purpose and advantages of the disclosed subject matter will be set forth in and apparent from the description that follows, as well as will be learned by practice of the disclosed subject matter. Additional advantages of the disclosed subject matter will be realized and attained by the methods and systems particularly pointed out in the written description and claims hereof, as well as from the appended drawings.
- To achieve these and other advantages and in accordance with the purpose of the disclosed subject matter, as embodied and broadly described, the disclosed subject matter includes a peristaltic pump for delivery of a beneficial agent to a user. The pump includes a motor, a cam shaft coupled to the motor for rotation about a longitudinal axis of the cam shaft, the cam shaft having at least one radially-outward projection defining a helical engagement portion disposed along a length of the cam shaft, and a plurality of finger plates disposed along the length of the cam shaft, each finger plate mounted for movement in a transverse direction relative to the longitudinal axis of the cam shaft, each finger plate having an aperture defined therein to receive the cam shaft therethrough, each aperture having a substantially straight edge region and an opposing edge region. Engagement of the helical engagement portion with the substantially flat edge region during rotation of the cam shaft urges the finger plate transversely toward an extended position.
- Additionally, and as embodied herein, the finger plate can be free of transverse movement as the helical engagement portion passes along at least a portion of the opposing edge region during rotation of the cam shaft. The opposing edge region can include an arcuate edge, and/or can include a gap. Each finger plate can have a recessed area in a surface proximate the aperture. The recessed area can be recessed 0.1 mm relative the surface of the finger plate. Each finger plate can include an end surface at an end facing the direction of the transverse movement. The recessed area can be disposed between the aperture and the end surface. Furthermore, the recessed area can be spaced from the end surface.
- Additionally, and as embodied herein, with each finger plate having an end surface at an end facing the direction of the transverse movement, the end surfaces of the finger plates together can define a contiguous surface facing the direction of the transverse movement. Each finger plate can be unbiased, or each finger plate can be biased away from the extended position. The plurality of finger plates can be disposed parallel with each other and arranged for sequential movement toward the extended position.
- In addition, and as embodied herein, the pump can further include a gap defined between an end plate of the plurality of finger plates and an interior wall of the peristaltic pump, wherein a filler plate can be disposed within the gap. The filler plate can have a different thickness than each of the plurality of finger plates. The different thickness can be less than each of the plurality of finger plates. Alternatively, the different thickness can be greater than each of the plurality of finger plates. The substantially straight edge region of the aperture likewise can have a thickness greater than the opposing edge region. Each finger plate can include a ceramic material. Additionally or alternatively, the camshaft can include a ceramic material.
- Additionally, and as embodied herein, the pump can include one or more bevel gears coupling the motor to the cam shaft. The cam shaft can include a chamfered portion formed at a radial end of the helical engagement portion. The helical engagement portion can extend around the cam shaft greater than one revolution of the helical engagement portion.
- Additionally, and as embodied herein, the pump can include a cassette including a cassette housing with a fluid reservoir defined therein and a delivery tube fluidly coupled with the fluid reservoir. The cassette housing can have a cassette base region, and the pump can include a receiving region to receive the cassette base region with, the plurality of finger plates disposed proximate the receiving region. Each finger plate thus can be configured to compress a portion the delivery tube in the extended position. When the cam shaft rotates out of engagement with the substantially straight edge region of each finger plate, the delivery tube can be configured to urge the finger plate away from the extended position. The plurality of finger plates can be disposed parallel with each other and arranged for sequential movement toward the extended position to sequentially compress the delivery tube to create a vacuum force to draw the beneficial agent from the fluid reservoir.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a fluid drive component disposed proximate the receiving region, a display to provide visual feedback to the user, a plurality of input buttons disposed on the pump housing, a first processor coupled to the fluid drive component and the display and configured to reduce power to or otherwise hibernate the fluid drive component and the display when the pump is in an inactive state, and a second processor coupled to the first processor and the plurality of input buttons. The second processor is configured to provide an activation signal to the first processor when one or more of the plurality of input buttons is deployed.
- Additionally or alternatively, the pump assembly can further include a radio-frequency identification (RFID) transceiver coupled to the first processor, and the first processor can be is configured to reduce power to the RFID transceiver when the pump is in the inactive state. The pump assembly can further include an occlusion sensor coupled to the first processor, and the first processor can be configured to reduce power to the occlusion sensor when the pump is in the inactive state.
- Furthermore, and as embodied herein, the pump assembly can further include a serial bus coupled to the first processor, and the first processor can be configured to reduce power to the serial bus when the pump is in the inactive state. The pump assembly can further include a power supply voltage monitor coupled to the second processor, and the second processor can be configured to maintain the power supply voltage monitor in an active state when the first processor is powered down. The pump assembly can further include one or more memories, a primary power supply and a backup power supply coupled to the second processor, and the second processor can be configured to utilize the backup power supply to save present data to the one or more memories when the second processor detects the primary power supply is removed or disabled.
- In addition, and as embodied herein, the pump assembly can further include a battery coulomb counter coupled to the second processor, and the second processor can be configured to maintain the battery coulomb counter in an active state when the first processor is powered down. The pump assembly can further include a speaker, and the first processor and the second processor each can be coupled to the speaker and configured to send an audio signal to the speaker when a fault is detected.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a primary power source, a secondary power source coupled to the primary power source, a fluid drive component disposed proximate the receiving region and coupled to the primary power source isolated from the secondary power source, a first processor coupled to the primary power source and the secondary power source, a second processor coupled to the first processor, the primary power source and the secondary power source, one or more memories coupled to the first processor. At least one of the first processor and the second processor is configured, when the primary power source is removed or disabled, to utilize the secondary power source and the first processor to complete writing operations to the one or more memories prior to depletion of the secondary power source.
- Additionally, and as embodied herein, the secondary power source can include a 1F capacitor. The secondary power source can be coupled to the primary power source via a secondary power source charger configured to charge the secondary power source when the primary power source is active. The one or more memories can include a nonvolatile memory storage.
- Furthermore, and as embodied herein, the pump assembly can further include an RFID transceiver coupled to the secondary power source. The pump assembly can further include a speaker coupled to the secondary power source. The first processor and the second processor each can be coupled to the speaker, directly or via an audio amplifier, and configured to send an audio signal to the speaker when a fault is detected. The pump assembly can further include a display to provide visual feedback to the user. The display can be coupled to the primary power source and isolated from or otherwise not connected to the secondary power source. The pump assembly can further include an occlusion sensor coupled to the primary power source and isolated from the secondary power source.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a fluid drive component disposed proximate the receiving region, a main controller circuit board coupled to and configured to control the fluid drive component, and at least one secondary circuit board foldably joined to the main controller circuit board through a flexible substrate and disposed within the interior in a stacked relationship relative the main controller circuit board. A plurality of such secondary circuit boards can be provided, each joined to the main controller circuit board by a flexible substrate either directly or indirectly.
- For example, and as embodied herein, the at least one secondary circuit board can include a power source controller board coupled to a power source. The at least one secondary circuit board can include an occlusion sensor controller board coupled to an occlusion sensor. The at least one secondary circuit board can include a serial bus controller board. The serial bus controller board can include an electromagnetic compatibility component. The serial bus controller board can include a serial bus port disposed proximate an exterior wall of the pump housing and aligned with an aperture in the exterior wall.
- Furthermore, and as embodied herein, the at least one secondary circuit board can include a motor signal encoder coupled to the fluid drive component. The fluid drive component can be coupled to the motor signal encoder in a stacked relationship with the main controller circuit board. The at least one secondary circuit board can include a speaker, alone or with an audio amplifier. The at least one secondary circuit board can include a haptic actuator.
- In addition, and as embodied herein, the at least one secondary circuit board can include a display controller coupled to a display. The display can further include a liquid crystal display (LCD). The display can further include a flexible light transmission component in optical communication with the LCD. The at least one secondary circuit board can include an input controller. The input controller board can include a plurality of input buttons disposed proximate an exterior wall of the pump housing and aligned with corresponding apertures in the exterior wall. The pump housing can have an interior having a height within a range of 18.5 mm to 20 mm. The flexible substrate can include polyimide, copper-clad polyimide, polyether ether ketone, transparent conductive polyester film, or a combination thereof. The flexible substrate can have a thickness within a range of 95 μm to 192.5 μm.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, the pump housing having a receiving region to receive the cassette base region, the fluid drive component disposed proximate the receiving region. The contact force sensor is in communication, such as by direct or indirect contact, with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device includes one or more processors in communication with the contact force sensor to receive data representing the measured force or pressure from the contact force sensor, the one or more processors configured to determine a maximum force value detected by the contact force sensor during an initial pumping cycle, the maximum force value corresponding to a baseline maximum force value, obtain subsequent force values from the contact force sensor during each subsequent pumping cycle, and determine an occlusion is present if one or more of the subsequent force values exceed the baseline maximum force value by a threshold amount.
- Additionally, and as embodied herein, the one or more processors can be further configured to determine a subsequent maximum force value during the subsequent pumping cycle, and adjust the baseline maximum force value to the subsequent maximum force value if the subsequent maximum force value is less than the baseline maximum force value. The threshold amount can be about 10% of the baseline maximum force value.
- Furthermore, and as embodied herein, the one or more processors can be further configured to determine a local maximum force value during an initial pump revolution of each pump cycle, the local maximum force corresponding to a baseline local maximum force value, obtain a subsequent local force maximum during each subsequent pump revolution of each pump cycle, and determine an occlusion is present if one or more of the subsequent local force maxima exceeds the baseline local maximum force value by a local threshold amount. The local threshold amount can be about 13% of the baseline local maximum force value. The one or more processors can be further configured to determine the local maximum force value of each pump cycle when a flow rate of the fluid drive component is above a threshold flow rate. The threshold flow rate can be 10 mL/hr.
- Furthermore, and as embodied herein, the one or more processors can be further configured to determine a local minimum force value detected by the contact force sensor during each revolution of each pumping cycle, and determine an error is present if the local minimum force value does not exceed the local maximum force value of a corresponding pump cycle by a local minimum threshold amount. The error can include a mechanical failure of the fluid drive component. The error can include an occlusion signal circuitry failure. A duration of each pumping cycle can be determined at least in part by a flow rate of the fluid drive component.
- In addition, and as embodied herein, the device can further include a motor operatively coupled to the fluid drive component, and a rotational position sensor operatively coupled to the motor to determine a rotational position of the motor. The one or more processors can be further operatively coupled to the rotational position sensor, and the one or more processors can be further configured to determine each pump revolution from the rotational position sensor. The one or more processors can be further configured to stop the fluid drive component when the occlusion is determined to be present. The device can further include a display operatively coupled to the one or more processors, and the one or more processors can be further configured to display an error signal on the display when the occlusion is determined to be present. The contact force sensor can include a single contact force sensor. The one or more processors can be further configured to apply a four-sample moving average filter to the data representing the measured force or pressure from the contact force sensor.
- According to another aspect of the disclosed subject matter, and further to the above, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump, a lock member, and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, the pump housing having a receiving region to receive the cassette base region, the fluid drive component disposed proximate the receiving region. The lock member is coupled to the pump housing and movable between an open position and a closed position, the cassette capable of being inserted into and removed from the receiving region when the lock member is in the open position, and the cassette being secured to the pump with the cassette base region within the receiving region and a length of the delivery tube in operative engagement with the fluid drive component when the lock member is in the closed position. The lock member includes a proximity tag configured to be disposed proximate the proximity sensor when the lock member is in the closed position. The contact force sensor is in communication with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device further includes one or more processors in communication with the proximity sensor and the contact force sensor to receive a proximity signal and contact force data, respectively, therefrom, the one or more processors configured to determine whether the lock member is in the closed position using the proximity signal, determine whether the delivery tube is in operative engagement with the fluid drive component using the contact force data; and enable operation of the fluid drive component if the lock member is determined to be in the closed position and the delivery tube is determined to be in operative engagement with the fluid drive component.
- Additionally, and as embodied herein, the proximity sensor can include a reed switch. The proximity tag can include a magnet. The one or more processors can be further configured to compare the contact force data to a threshold value, and determine the delivery tube is in operative engagement with the fluid drive component if the contact force data exceeds the threshold value. The one or more processors can be further configured to determine a local minimum force value detected by the contact force sensor during each revolution of each pumping cycle, and determine the delivery tube is in operative engagement with the fluid drive component if the local minimum force value exceeds the local maximum force value of a corresponding pump cycle by a local minimum threshold amount.
- Furthermore, and as embodied herein, a cassette base region can include a RFID tag. The receiving region can include a RFID reader configured to read the RFID tag when the cassette is secured to the pump. The one or more processors can be further configured to receive identification information for the cassette encoded on the RFID tag from the RFID reader, determine whether the identification information is valid, and enable operation of the fluid drive component if the identification information is valid. The RFID tag can further include an expiration date of the beneficial agent, and the one or more processors can be further configured to receive the expiration date of the beneficial agent from the RFID reader, determine whether the expiration date is exceeded, and enable operation of the fluid drive component if the expiration date is not exceeded. The RFID tag can include high or ultra-high radio frequency ID.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump, a lock member, and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region including a RFID tag. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, a proximity sensor and a RFID reader, the pump housing having a receiving region to receive the cassette base region, the fluid drive component, proximity sensor and RFID reader disposed proximate the receiving region. The lock member is coupled to the pump housing and movable between an open position and a closed position, the cassette capable of being inserted into and removed from the receiving region when the lock member is in the open position, and the cassette being secured to the pump with the cassette base region within the receiving region and a length of the delivery tube in operative engagement with the fluid drive component when the lock member is in the closed position. The lock member includes a proximity tag configured to be disposed proximate the proximity sensor when the lock member is in the closed position. The contact force sensor is in communication with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device further includes one or more processors in communication with the proximity sensor, the contact force sensor and the RFID reader to receive a proximity signal, contact force data and identification information for the cassette encoded on the RFID tag, respectively, therefrom, the one or more processors configured to determine whether the lock member is in the closed position using the proximity signal, determine whether the delivery tube is in operative engagement with the fluid drive component using the contact force data, determine whether the identification information is valid, and enable operation of the fluid drive component if the lock member is determined to be in the closed position, the delivery tube is determined to be in operative engagement with the fluid drive component, and the identification information is determined to be valid.
- Furthermore, and as embodied herein, the one or more processors can be further configured to receive identification information for the cassette encoded on the RFID tag from the RFID reader, determine whether the identification information is valid, and enable operation of the fluid drive component if the identification information is valid. The RFID tag can further include an expiration date of the beneficial agent, and the one or more processors can be further configured to receive the expiration date of the beneficial agent from the RFID reader, determine whether the expiration date is exceeded, and enable operation of the fluid drive component if the expiration date is not exceeded. The RFID tag can include high or ultra-high radio frequency ID.
- For each of the aspects described above, the device and/or cassette can include a beneficial agent contained in the fluid reservoir. The beneficial agent can include one or more of levodopa and carbidopa. Furthermore, the various aspects above can be combined to provide a device, pump and/or cassette with selected features and combinations of features as desired.
- It is to be understood that both the foregoing general description and the following detailed description are exemplary and are intended to provide further explanation of the disclosed subject matter claimed.
- The accompanying drawings, which are incorporated in and constitute part of this specification, are included to illustrate and provide a further understanding of the disclosed subject matter. Together with the description, the drawings serve to explain the principles of the disclosed subject matter.
-
FIG. 1A is an exploded perspective view of an exemplary device for delivering a beneficial agent according to the disclosed subject matter. -
FIG. 1B is an exploded schematic view of an exemplary embodiment of a pump assembly according to the disclosed subject matter. -
FIG. 2A is a perspective view of an exemplary occlusion block of the pump assembly ofFIG. 1B . -
FIG. 2B is a perspective view of the occlusion block ofFIG. 2A joined to an exemplary base block of the pump assembly ofFIG. 1B . -
FIG. 2C is a perspective view of exemplary finger plates joined to the base block ofFIG. 2B . -
FIG. 2D is a perspective view of an exemplary cam shaft joined to the base block ofFIG. 2C . -
FIG. 2E is a perspective view of an exemplary motor assembly joined to the base block and cam shaft ofFIG. 2D , with portions cut away for purpose of illustration. -
FIG. 2F is a detail view of a portion ofFIG. 2E . -
FIG. 2G is a detail perspective view of an exemplary lock member joined to the base block ofFIG. 2F . -
FIG. 2H is a bottom plan view of the pump assembly ofFIG. 2G . -
FIG. 3A is a front view of an exemplary embodiment of a finger plate for use with the pump assembly ofFIG. 1B , the rear view being substantially similar. -
FIG. 3B is a left side view of the finger plate ofFIG. 3A , the right side view being substantially similar. -
FIG. 3C is a bottom view of the finger plate ofFIG. 3A . -
FIG. 3D is a top right perspective view of the finger plate ofFIG. 3A . -
FIG. 4A is a front view of an alternative embodiment of a finger plate for use with the pump assembly ofFIG. 1B , the rear view being substantially similar. -
FIG. 4B is a left side view of the finger plate ofFIG. 4A , the right side view being substantially similar. -
FIG. 4C is a bottom view of the finger plate ofFIG. 4A . -
FIG. 4D is a top right perspective view of the finger plate ofFIG. 4A . -
FIG. 5A is a front view of another alternative embodiment of a finger plate for use with the pump assembly ofFIG. 1B , the rear view being substantially similar. -
FIG. 5B is a left side view of the finger plate ofFIG. 5A , the right side view being substantially similar. -
FIG. 5C is a bottom view of the finger plate ofFIG. 5A . -
FIG. 5D is a top right perspective view of the finger plate ofFIG. 5A . -
FIG. 6A is a plan view of an exemplary cam shaft joined with an exemplary bevel gear for use with the pump assembly ofFIG. 1B . -
FIG. 6B is a plan view of the exemplary cam shaft ofFIG. 6A . -
FIG. 6C is a cross-sectional view of the exemplary cam shaft taken alongline 6C-6C ofFIG. 6B . -
FIG. 6D is a cross-sectional view of the exemplary cam shaft taken alongline 6D-6D ofFIG. 6B . -
FIG. 6E is a front view of the exemplary bevel gear ofFIG. 6A . -
FIG. 6F is a right side view of the exemplary bevel gear ofFIG. 6E , the left side view being substantially similar. -
FIG. 6G is a side view of the exemplary bearing ofFIG. 6A . -
FIG. 6H is a cross-sectional view of the exemplary bearing ofFIG. 6G taken alongline 6H-6H ofFIG. 6G . -
FIGS. 7A-7C each is an alternative embodiment of a cam shaft protrusion according to the disclosed subject matter, each illustrating an alternative cam shaft contacting surface. -
FIG. 8A is a partial cross-sectional view taken along a longitudinal axis of the exemplary cam shaft, illustrating the cam shaft interacting with exemplary finger plates of the pump assembly ofFIG. 1B . -
FIG. 8B is a partial cross-sectional view taken along an axis transverse to the longitudinal axis of the cam shaft ofFIG. 8A , illustrating the cam shaft interacting with exemplary finger plates of the pump assembly ofFIG. 1B . -
FIG. 8C is a partial cross-sectional view taken parallel to a longitudinal axis of the exemplary cam shaft and through a portion of the projection of the cam shaft, illustrating the portion of the projection interacting with exemplary finger plates of the pump assembly ofFIG. 1B -
FIG. 9 is a schematic diagram illustrating an exemplary circuit board assembly for a beneficial agent delivery device according to the disclosed subject matter. -
FIG. 10A is a perspective view of a physical layout of an exemplary circuit board assembly for a beneficial agent delivery device according to the disclosed subject matter. -
FIG. 10B is a side view of the exemplary circuit board assembly ofFIG. 10A . -
FIG. 10C is a top plan view of the exemplary circuit board assembly ofFIG. 10A . -
FIG. 10D is a bottom plan view of the exemplary circuit board assembly ofFIG. 10A . -
FIGS. 11A-11B together are a schematic diagram illustrating an exemplary delivery system for a beneficial agent delivery device according to the disclosed subject matter. -
FIGS. 12A-12B together are a schematic diagram illustrating exemplary power distribution for the delivery system ofFIGS. 11A-11B . -
FIG. 13 is a schematic diagram illustrating exemplary fluid drive component controller portion of the delivery system ofFIGS. 11A-11B . -
FIG. 14 is a schematic diagram illustrating exemplary techniques to control a fluid drive component for a beneficial agent delivery device according to the disclosed subject matter. -
FIG. 15 is a flow chart illustrating an exemplary technique for delivering a beneficial agent to a patient according to the disclosed subject matter. -
FIGS. 16A-16B each is a flow chart illustrating an exemplary technique for operating a beneficial agent delivery device according to the disclosed subject matter. -
FIGS. 17A-17M are diagrams illustrating exemplary techniques for occlusion detection and/or fault detection for a beneficial agent delivery device according to the disclosed subject matter. -
FIGS. 18A-1 to 18A-4 together are a schematic diagram illustrating exemplary techniques for providing a graphical user interface for a beneficial agent delivery device according to the disclosed subject matter. -
FIG. 18B is a flow chart illustrating exemplary techniques for providing a graphical user interface for a beneficial agent delivery device according to the disclosed subject matter. -
FIG. 18C-1 and 18-C-2 together are a schematic diagram illustrating an exemplary technique for providing a graphical user interface for a beneficial agent delivery device according to the disclosed subject matter. -
FIGS. 18D-1 to 18D-4 together are a schematic diagram illustrating exemplary techniques for providing a graphical user interface for a beneficial agent delivery device according to the disclosed subject matter. - Reference will now be made in detail to the various exemplary embodiments of the disclosed subject matter, exemplary embodiments of which are illustrated in the accompanying drawings. The structure and corresponding method of operation of and method of using the disclosed subject matter will be described in conjunction with the detailed description of the system.
- The apparatus and methods presented herein can be used for administering any of a variety of suitable therapeutic agents or substances, such as a drug or biologic agent, to a patient. For example, and as embodied herein, the device can include a pump joined to a cassette, which can include a fluid reservoir containing a fluid substance and can be joined to a delivery tube system. In operation, the pump can operate on the cassette to deliver the fluid substance through the tubing system. In this manner, the device is capable of administering a dosage of the fluid substance, such as a therapeutic agent, including a formulation in a liquid or gel form, through the delivery tube system and to a patient. In some embodiments, the fluid therapeutic agent can include one or more pharmaceutical or biologic agents. For example and without limitation, one such fluid therapeutic agent can be a central nervous system agent, such as levodopa. The central nervous system agent can be administered alone or in combination with, for example and without limitation, a decarboxylase inhibitor, such as carbidopa.
- In accordance with one aspect of the disclosed subject matter, a peristaltic pump for delivery of a beneficial agent to a user includes a motor, a cam shaft coupled to the motor for rotation about a longitudinal axis of the cam shaft, the cam shaft having at least one radially-outward projection defining a helical engagement portion disposed along a length of the cam shaft, and a plurality of finger plates disposed along the length of the cam shaft, each finger plate mounted for movement in a transverse direction relative to the longitudinal axis of the cam shaft, each finger plate having an aperture defined therein to receive the cam shaft therethrough, each aperture having a substantially straight edge region and an opposing edge region. Engagement of the helical engagement portion with the substantially flat edge region during rotation of the cam shaft urges the finger plate transversely toward an extended position.
- Additionally, and as embodied herein, the finger plate can be free of transverse movement as the helical engagement portion passes along at least a portion of the opposing edge region during rotation of the cam shaft. The opposing edge region can include an arcuate edge, and/or can include a gap. Each finger plate can have a recessed area in a surface proximate the aperture. The recessed area can be recessed 0.1 mm relative the surface of the finger plate. Each finger plate can include an end surface at an end facing the direction of the transverse movement. The recessed area can be disposed between the aperture and the end surface. Furthermore, the recessed area can be spaced from the end surface.
- Additionally, and as embodied herein, with each finger plate having an end surface at an end facing the direction of the transverse movement, the end surfaces of the finger plates together can define a contiguous surface facing the direction of the transverse movement. Each finger plate can be unbiased, or each finger plate can be biased away from the extended position. The plurality of finger plates can be disposed parallel with each other and arranged for sequential movement toward the extended position.
- In addition, and as embodied herein, the pump can further include a gap defined between an end plate of the plurality of finger plates and an interior wall of the peristaltic pump, wherein a filler plate can be disposed within the gap. The filler plate can have a different thickness than each of the plurality of finger plates. The different thickness can be less than each of the plurality of finger plates. Alternatively, the different thickness can be greater than each of the plurality of finger plates. The substantially straight edge region of the aperture likewise can have a thickness greater than the opposing edge region. Each finger plate can include a ceramic material. Additionally or alternatively, the camshaft can include a ceramic material.
- Additionally, and as embodied herein, the pump can include one or more bevel gears coupling the motor to the cam shaft. The cam shaft can include a chamfered portion formed at a radial end of the helical engagement portion. The helical engagement portion can extend around the cam shaft greater than one revolution of the helical engagement portion.
- Additionally, and as embodied herein, the pump can include a cassette including a cassette housing with a fluid reservoir defined therein and a delivery tube fluidly coupled with the fluid reservoir. The cassette housing can have a cassette base region, and the pump can include a receiving region to receive the cassette base region with, the plurality of finger plates disposed proximate the receiving region. Each finger plate thus can be configured to compress a portion the delivery tube in the extended position. When the cam shaft rotates out of engagement with the substantially straight edge region of each finger plate, the delivery tube can be configured to urge the finger plate away from the extended position. The plurality of finger plates can be disposed parallel with each other and arranged for sequential movement toward the extended position to sequentially compress the delivery tube to create a vacuum force to draw the beneficial agent from the fluid reservoir.
- Furthermore, and as embodied herein, the pump can further include a beneficial agent contained in the fluid reservoir. The beneficial agent can include one or more of levodopa and carbidopa.
- The accompanying figures, where like reference numerals refer to identical or functionally similar elements throughout the separate views, serve to further illustrate various embodiments and to explain various principles and advantages all in accordance with the disclosed subject matter. For purpose of explanation and illustration, and not limitation, exemplary embodiments of the pump assembly of the disclosed subject matter and components thereof are shown in the accompanying
FIGS. 1-8C . Furthermore, FIGS. 9 to 18D-4 each depicts techniques and corresponding systems for delivery of a beneficial agent to a user. Additionally, for example and without limitation, further details of exemplary cassettes and lock members for use with the pump assembly for delivery of a beneficial agent to a user, as discussed further below, are described in concurrently filed applications by Applicant, each entitled “DEVICES AND METHODS FOR DELIVERING A BENEFICIAL AGENT TO A USER,” Ser. Nos. ______ and ______, each of which is incorporated by reference in its entirety. - While the disclosed subject matter is described with respect to a delivery device to administer a dose of therapeutic agent, one skilled in the art will recognize that the disclosed subject matter is not limited to the illustrative embodiment, and that the devices disclosed herein can be configured for delivering any suitable substance therethrough. In addition, the components and the method of using the delivery device are not limited to the illustrative embodiments described or depicted herein. For example, the delivery device embodied herein can be used with other tubing assemblies and components thereof for similar benefits and advantages, and are not limited for use with the delivery tubing herein.
- Referring to an illustrative embodiment of
FIG. 1A , adelivery device 1000 includes acassette 1010 and apump 1030.Cassette 1010 includes acassette housing 1011 with a fluid reservoir defined therein and acassette base region 1012. Adelivery tube 1020 is fluidly coupled with the fluid reservoir.Pump 1030 or pump device can include apump housing 1031 with apump assembly 100 disposed therein.Pump housing 1031 can include a receivingregion 1032 configured to receivecassette base region 1012. As described further below,pump assembly 100 includes alock member 11 coupled to pumphousing 1031 and movable between an open position and a closed position.Cassette 1010 is capable of being inserted into and removed from the receivingregion 1032 when thelock member 11 is in the open position, and thecassette 1010 is secured to thepump 1030 with thecassette base region 1012 within the receivingregion 1032 and a length of thedelivery tube 1020 in operative engagement with thepump 1030 when thelock member 11 is in the closed position. - Referring to an illustrative embodiment of
FIG. 1B ,pump assembly 100 can include a pumpmechanism base block 1 and acam shaft 2 joined thereto. Amotor assembly 3 can be joined to thecam shaft 2, for example and as embodied herein, usingbevel gears 6 disposed at a 90 degree angle from each other to transmit rotational force from themotor assembly 3 to thecam shaft 2. A plurality offinger plates 4 can be disposed along the longitudinal axis of thecam shaft 2. As embodied herein, each of thefinger plates 4 can have the same dimensions. Additionally or alternatively, finger plates can be included that have different dimensions than other finger plates. For example and not limitation,finger plate 4 a can have a thickness less than the thickness of thefinger plates 4, and/orfinger plate 4 b can have a thickness greater than the thickness of thefinger plates 4. For purpose of illustration and not limitation, as embodied herein,finger plate 4 a can have a thickness of 0.60 mm,finger plates 4 can have a thickness of 0.74 mm, andfinger plate 4 b can have a thickness of 0.90 mm. For purpose of illustration and not limitation, and as embodied herein, the tolerance of the finger thickness can be +/−0.025 mm. - With reference to
FIG. 1B ,base block 1 can be provided to mount an occlusion sensor on thebase block 1, as discussed further herein. For example and not limitation, such mounting can reduce the space occupied by the occlusion sensor and improve its accuracy compared to mounting the occlusion sensor on the pump housing. As embodied herein,motor 3 can be cylindrical. For example and not limitation, themotor 3 can have a length-to-width ratio of about 3.5:1 or greater, and as embodied herein can have a length-to-width ratio of about 5.1:1. Furthermore, and as embodied herein,motor 3 can be a coreless DC motor. - For purpose of illustration and not limitation,
base block 1 can be formed by any suitable material (e.g., plastic, composites, metal, etc.), such as by machining, molding or the like. For example and not limitation, the material can be a metal such as 6061-T6 aluminum alloy. Additionally or alternatively, thebase block 1 can include a finish, such as hard anodized per MIL-A-8625, TYPE III,class 2. The finish can be any desired or suitable color (e.g. black), and can have any suitable thickness, for example a thickness of at least 0.015 mm. Anodization can be applied selectively to pump components, such asbase block 1, including for example pump components in electrical communication to provide suitable equipment grounding. For purpose of illustration and not limitation, a label including a part number can be included, for example, on the bottom side of thebase block 1. - As embodied herein, an
occlusion block 9 can be provided. Extension springs 8 can be secured toocclusion block 9, for example by inserting eachspring 8 through clearance holes inocclusion block 9, inserting spring retention pins (not shown) through the holes and urging the pins into theocclusion block 9. The assembledocclusion block 9 can be inserted into the pumpmechanism base block 1. - Additionally, a
lock member 11 can be assembled onto thepump base 1. For example, arear pin 10 can be inserted into thepump base 1 to secure apin driver 13, which can be configured with an upward-facing notch. Thelock member 11,pin driver 13 and torsion springs 12, 20 can be aligned and alatch hinge pin 15 can be inserted intolock member 11 and through thepin driver 13 and torsion springs 12, 20. One ormore set screws 23 can be inserted intopump base 1 to adjust theocclusion block 9 position, as discussed herein. Spring retainer pins 17 can be inserted intopump mechanism base 1, and a free end of extension springs 8 can be urged over spring the retainer pins 17, which can be press fit intopump mechanism base 1 to secure the extension springs 8. - For example and not limitation, the
occlusion block 9 can be moved into place by thelock member 11. Theocclusion block 9 can be positioned to correspond to a desired occlusion percentage, for example within a range of 20% to 30% occlusion. Occlusion percentage O can be calculated based on the tubing wall thickness W and the occlusion distance D (e.g. the distance between theocclusion block 9 and the finger plates 4) using the equation O=100%*(1−(D/(2*W))). For purpose of illustration and not limitation, 100% occlusion can occur when D=0, which can correspond to thefinger plates 4 in engagement with theocclusion block 9, that is without any space for a tube therebetween. Similarly, 0% occlusion can occur when D=2*W, which can correspond to the tubing being compressed by thefinger plates 4 andocclusion block 9 such that inner walls of the tubing are proximate to or engaging each other. Accordingly, a 25% occlusion can correspond to the thickness of the walls of the tubing being compressed by 25% by thefinger plates 4 andocclusion bock 9. Occlusion percentage can refer to the peak occlusion caused by thefinger plates 4 during the overall stroke of thefinger plates 4. Suitable occlusion, which can be within a range of about 24% to about 29%, and as embodied herein at about 27.5%, can prevent backflow and increase repeatability. Additionally, thelock member 11 configured to move theocclusion block 9 into place can affect the occlusion percentage tolerance, as discussed further herein. - For purpose of illustration and not limitation, an
alignment pin 10 can be included and configured to move with thelock member 11 to insert into a drug cartridge brought into alignment with the pump and secured with thelock member 11. Insertion of thealignment pin 10 into the cartridge can reduce rocking of the drug cartridge and ensure proper alignment of the cartridge with the pump. Additionally or alternatively, thebase block 1 can be adjusted to support greater pin stroke. For purpose of illustration and not limitation, mounting for torsion springs 12, 20 can be mounted to or integral with thebase block 1. - A plurality of
finger plates 4 can be placed in the cavity of the pumpmechanism base block 1, as discussed herein. A gap can be defined between anend finger plate 4 and the inside wall of thebase block 1, and as such, a non-standard thickness finger plate(s) 4 a, 4 b can be selected with a suitable thickness(es) and inserted to fill any such gap remaining between theend finger plate 4 and the inside wall of thebase block 1. As discussed herein, thecam shaft 2 can be threaded through the apertures of thefinger plates 4 and rotatably mounted at either end by mounting holes in the pumpmechanism base block 1 forcam shaft bearings 19.Cam shaft bearings 19 can be inserted into pumpmechanism base block 1 and press fit to secure thecam shaft 2 to thebase block 1.Bevel gear 6 can be disposed at an exposed end ofcam shaft 2, as discussed herein. - The distance or gap between the
occlusion block 9 and theperistaltic finger plates 4 can be adjusted using setscrews 23 to adjust the location of thehinge pin 15. For purpose of illustration and not limitation, thehinge pin 15 can determined the position of thelock member 11 and the location of theocclusion block 9. Set screws 23 can be tightened to urge thelatch hinge pin 15 to an initial position. The bevel gears 6 can be rotated to position thefinger plates 4, as shown for purpose of illustration and not limitation. Theouter finger plates 4 can initially be closest to theocclusion block 9. Therear pin 10 can be inserted and thelock member 11 can be closed. To calibrate the distance or gap between thefinger plates 4 and theocclusion block 9, an object of a known thickness can be inserted into the gap formed between thefinger plates 4 and theocclusion block 9. For example and not limitation, as embodied herein, the object can be a pin with a known thickness, such as a 0.112″ gauge pin. For purpose of illustration and not limitation, the object can be inserted into the gap formed between thefinger plates 4 and theocclusion block 9 on the inlet side. If the object drops passes through the gap, theset screws 23 on that side can be adjusted to decrease the gap. The inserting of the object through the gap can be repeated on the inlet side until the object does not pass through. Additionally, another object of a slightly less thickness can be passed through the gap to confirm that the gap has the desired size. For example and not limitation, as embodied herein, the other object can be a pin of a smaller gauge such as a 0.111″ gauge pin. If the other object passes through the gap, the gap is appropriately sized. If the other object does not pass through the gap, the set screws can be adjusted to increase the gap. This process can be repeated at the outlet side. - The
lock member 11 can be configured as a cam lever and actuated to move theocclusion block 9 into place when loading a new tube. Therear pin 10 can operate to stabilize the tubing cartridge in the housing, and can be actuated whenlock member 11 is actuated. Torsion springs 12, 20 can lift thelock member 11, for example, when thelock member 11 is not fully seated. Extension spring(s) 8 can urge the occlusion block away from thefinger plates 4 when thelock member 11 is lifted. - For purpose of illustration and not limitation, a
top cover 14 can be provided. Thetop cover 14 can be secured withscrews 18. Additionally or alternatively, amagnet 22 can be included. For example and not limitation, themagnet 22 can be included in thelock member 11. A sensor (not pictured) can be added to thebase block 1 to sense themagnet 22. For example, the sensor can be a reed switch, which can be operated by the magnetic field of themagnet 22 whenlock member 11 is in the closed position. As such themagnet 22 and sensor can help to ensure proper and safe operation of thepump assembly 100. - As embodied herein, the
motor assembly 3 can be mounted to the base block. For example and not limitation, such mounting can reduce the space occupied by thepump assembly 1700 compared to mounting themotor assembly 3 to the pump housing. - With reference to views of the various components as depicted in
FIGS. 2A-2H , thepump assembly 100 can be configured as follows. Anocclusion block 9 can be provided, for example as shown inFIG. 2A . Extension springs 8 can be secured toocclusion block 9, for example by inserting eachspring 8 through clearance holes inocclusion block 9 and insert spring retention pins 8 a through the holes and pressing the pins into theocclusion block 9. The assembledocclusion block 9 can be inserted into the pumpmechanism base block 1, as shown for example inFIG. 2B . Spring retainer pins 17 can be inserted intopump mechanism base 1, and a free end of extension springs 8 can be urged over spring retainer pin, which can be press fit intopump mechanism base 1 to secure the extension springs 8. - A plurality of
finger plates 4 can be placed in the cavity of the pumpmechanism base block 1, as shown for example inFIG. 2C . As embodied herein, for purpose of illustration, twenty-sevenfinger plates 4 are depicted, and are slidably disposed between end walls of thebase block 1. A gap can be defined between anend finger plate 4 and the inside wall of thebase block 1, and as such, a non-standardthickness finger plate end finger plate 4 and the inside wall of thebase block 1. Eachfinger plate 4 has anaperture 41 defined therethrough, as described further below, which is aligned with mountingholes 1 a shown inFIG. 2C . - The
cam shaft 2 is provided with a radially-outward projection 21 as described further below, and threaded through theapertures 41 of thefinger plates 4 and mountingholes 1 a ofbase block 1, as shown for example inFIG. 2D . In this manner,cam shaft 2 is rotatably mounted at either end by mountingholes 1 a in the pumpmechanism base block 1 withcam shaft bearings 19, as described further below. That is,cam shaft bearings 19 can be inserted into pumpmechanism base block 1 and press fit to secure thecam shaft 2 to thebase block 1. Abevel gear 6 can be disposed at an exposed end ofcam shaft 2. As embodied herein, a pin hole onbevel gear 6 andcam shaft 2 can be aligned, and a bevel gear retaining pin (not shown) can be inserted therein and press fit into the gear/shaft assembly. - With reference to
FIG. 2E , the motor assembly can include a motor, gearbox and encoder. Aside mount bracket 33 can be installed over a face of themotor 3, as shown, and can be secured to themotor 3, forexample using screws 33 a. Alternatively, a mount bracket for the motor assembly can be integral withbase block 1. Abevel gear 6 can be inserted onto an end of a shaft ofmotor 3, and a pin hole inbevel gear 6 can be aligned with a pin hole on the shaft. A gear pin can be inserted into the pin hole and press fit to secure thebevel gear 6 to themotor 3. In this manner, the motor assembly is adjustable relative thebevel gear 6 andcam shaft 2 for proper alignment. Motor assembly can include anencoder 3 a configured to provide position and/or speed control ofmotor 3, as described further herein. - Mount bracket to mount
motor assembly 3 can be aligned with mounting holes provided in the pumpmechanism base block 1 and secured, for example using mounting screws. A gap between theocclusion block face 9 and the surface of thefinger plates 4 can be formed, and can be adjusted using the occlusion block set screws, as discussed herein, to a predetermined dimension. The dimension can be suitable to allow the finger plates to contact and compress a liquid or gel-containing peristaltic tube therein. - As shown for example in
FIGS. 2F-2H , alock member 11 can be assembled onto thepump base 1. For example, arear pin 10 can be inserted into thepump base 1 to secure apin driver 13 having an upward-facing notch, as shown for example inFIG. 2F . Thelock member 11,pin driver 13 andtorsion spring 12 can be aligned and alatch hinge pin 15 can be inserted into thelock member 11 and through thepin driver 13 andtorsion spring 12. One ormore set screws 18 can be inserted intopump base 1 to adjust theocclusion block 9 position, as discussed further herein. - Referring now to
FIGS. 3A-3D , an exemplary embodiment of afinger plate 4 is shown.Finger plates 4 each have recessedareas 42 in at least one side surface thereof,proximate opening 41. As depicted herein, the recessedareas 42 reduce surface friction betweenadjacent finger plates 4 during movement relative one another. For example, and as embodied herein, eachrecess 42 can have a depth of about 0.1 mm relative to the corresponding surface of thefinger plate 4. As further depicted herein, the recessed area of eachfinger plate 4 does not extend to the surface of the finger plate disposed adjacent the peristaltic tube. In this manner, thetube interaction surface 43 of eachfinger plate 4 is generally planar and together thefinger plates 4 can define a contiguous surface for improved pumping performance and accuracy. - As embodied herein, the
finger plates 4 can be symmetrical. For purpose of illustration and not limitation, thefinger plate 4 can have a D-shapedopening 41. The shape of opening 41 can improve moldability, for example by allowing material to flow into each part of a mold more easily compared to other opening shapes, e.g., rectangular. To strengthen the flat portion of the D-shape opening 41, the amount of material proximate the area of contact withcamshaft 2 can be increased. For purpose of illustration and not limitation, thefinger plates 4 can be made of any suitable material (e.g., plastic, ceramic, composites, metal, etc.). For example, the finger plates can be made out of a plastic, such as commercially available Delrin 520MP or RTP 1399, or ceramic material. - With reference to
FIGS. 4A-4D , an alternative embodiment of afinger plate 4′ is shown, having alternative dimensions compared tofinger plate 4. Referring now toFIGS. 5A-5D , an alternative embodiment of afinger plate 4″ is shown, having alternative dimensions compared tofinger plate 4. For purpose of illustration and not limitation, optional smaller finger plate(s) 4 a and larger finger plate(s) 4 b can be included. For example and not limitation, during assembly the overall dimensions of the combinedfinger plates 4 can be evaluated, andcertain finger plates 4, for example one or moreend finger plates 4 can be replaced with asmaller finger plate 4 a or alarger finger plate 4 b to achieve a desired fit. -
FIG. 6A illustrates anexemplary camshaft 2, bearing 19, andbevel gear 6.FIGS. 6B-6D illustrate further features ofexemplary camshaft 2. AdditionallyFIGS. 6E-6F illustrate further features ofexemplary bearing 19.FIGS. 6G-6H illustrate further features ofexemplary bevel gear 6. With reference toFIGS. 6A-6H , for purpose of illustration and not limitation,camshaft 2 can have increased load capacity compared to certain cam shafts for similar applications. For example and not limitation, the journal diameter can be 50% greater than certain camshafts for similar applications. Additionally, thecamshaft 2 can be made of any suitable material (e.g., plastic, ceramic, composites, metal, etc.). For example, and as embodied herein, the material can be a ceramic material, such as and without limitation, zirconium oxide ceramic.Camshaft 2 can be lubricated with any suitable lubricant to reduce frictional forces, such as, without limitation, DuPont™ Krytox® GPL205, TURMOGREASE Highspeed L 182 (LUBCON Turmo® Lubrication), TURMOPOL GREASE LC 2201 (LUBCON Turmo® Lubrication) and Turmopol Oil 68 HT (LUBCON Turmo® Lubrication). Furthermore, and as embodied herein, thecam shaft 2 can include a chamfered portion formed at the end of the helical portion to prevent contact with theouter bearing 19. Additionally, and as embodied herein, the tolerances of the attachment of thecamshaft 2 to thebevel gear 6 can be improved by using an over moldedbevel gear 6, as compared to, e.g., a pin. Using an over moldedbevel gear 6 can also reduce manufacturing steps of thepump assembly 1700. -
FIGS. 7A-7C show the profile for the contacting surfaces of exemplary camshafts. For purpose of illustration and not limitation, certain other camshafts for similar applications can be configured with a generally flat surface to contact the finger plates. For purpose of comparison, as shown for example inFIG. 7A , a rounded profile for contacting can create a point contact that can wear down the flat section of the opening in thefinger plates 4 and distort the shape of the opening. As embodied herein. theexemplary camshaft 2 can have a flattened egg shape for the profile of the helical camshaft, as shown for example inFIG. 7C . The egg shape can distribute the force from thecamshaft 2 to thefinger plates 4 over a larger surface. As such, the overall wear of thecamshaft 2 on thefinger plates 4 can be reduced. - Referring now to
FIGS. 8A-8C , exemplary features of the interaction ofcamshaft 2 withfinger plates 4 are illustrated. In operation, thepump assembly 100 can operate as a fluid drive component. As embodied herein, themotor 3 turnsbevel gears 6, which turnscam shaft 2. As shown for example inFIGS. 6A-6D ,cam shaft 2 has a radially-outward projection 21 defining a helical engagement portion disposed along a length of thecam shaft 2.FIGS. 8A-8C each is a cross-sectional schematic diagram illustrating thefinger plates 4 interacting with thecam shaft 2 and theocclusion block 9. As shown inFIG. 8A ,projection 21 engagesfinger plates 4 to urge eachfinger plate 4 transversely in sequence towardocclusion block 9 to compress an adjacent portion of a peristaltic tube (not shown) disposedproximate occlusion block 9. The compression of the peristaltic tube urges a liquid or gel within the peristaltic tube in a direction out of the peristaltic tube. Further rotation of thecam shaft 2 urges eachfinger 4 plate away fromocclusion block 9 to release the peristaltic tube. The release of the compressed peristaltic tube thus can create a vacuum force within the peristaltic tube to draw additional fluid from the fluid source into the peristaltic tube. In this manner, and as discussed further herein, the position of thefinger plates 4 with respect to the peristaltic tube is controlled by the angular position of therotatable cam shaft 2 within theaperture 41. Additionally or alternatively, thefinger plates 4 can be biased, for example toward the return position away fromocclusion block 9. - As embodied herein, the
camshaft 2 can have a round lobe orprojection 21 that wraps around the shaft in a helical shape. The helical shape of theprojection 21 can wrap around thecamshaft 2 slightly greater than one revolution. As such, in operation, as thecamshaft 2 rotates, at least a portion of thecamshaft 2 can be acting on a sufficient number offinger plates 4 to ensure the tubing interfacing with thefinger plates 4 remains occluded throughout each rotation. In this manner, fluid can be urged to flow in a single direction. - The interaction of the
camshaft 2 with the D-shapedopening 41 of aseries finger plates 4 can produce a peristaltic pumping motion. Thehelical lobe 21 can exert a force on thefinger plates 4 as it rotates, which can result in motion of thefinger plates 4 perpendicular to thecamshaft 2, as shown for example inFIG. 8C . Additionally, as shown for example inFIG. 8B , as thecamshaft 2 rotates, the portion of thecamshaft 2projection 21 engaging thefinger plate 4 can urge thefinger plate 4 at different locations within the D-shapedopening 41. For example and not limitation, thecamshaft 2 and theopening 41 can be configured such that contact can be made with a central portion of the flat and curved portions of the D-shapedopening 41 and no contact can be made with outer corner portions of theopening 41, for example as illustrated inFIG. 8B . As no contact can be made with the outer corner portions of the D-shapedopening 41, thefinger plates 4 can be urged to move in a single axis. Thecamshaft 2 can also include an over moldedbevel gear 6 formed at an end thereof for coupling with themotor 3 and mounting features of thebase block 1 to hold thecamshaft 2 in thepump assembly 100, as described herein. - Referring now to
FIG. 8B , eachfinger plate 4 has anaperture 41 to receive thecam shaft 2 proximate a segment ofengagement portion 21. Eachaperture 41 depicted herein has a substantiallyflat edge 44 at a first end proximate theocclusion block 9, and a substantiallyarcuate edge 45 at a second end opposite the first end. With reference toFIG. 8B , rotation of thecam shaft 2 andengagement portion 21 rotatesengagement portion 21 into engagement with the substantiallyflat edge 44, and urgesfinger plate 4 toward occlusion block 9 a distance to urge the peristaltictube engagement surface 43 into engagement with a peristaltic tube disposed therein. Further rotation of thecam shaft 2 maintainsengagement portion 21 in engagement withflat edge 44 and maintainsfinger plate 4 in engagement with the peristaltic tube. Rotation ofcam shaft 2 andengagement portion 21 beyondflat edge 44 movesengagement portion 21 along a side of theaperture 41 and into engagement witharcuate edge 45, which urgesfinger plate 4 away fromocclusion block 9 and out of engagement with the peristaltic tube. Alternatively, for purpose of illustration and not limitation,finger plates 4 can be biased away fromocclusion block 9 along the single axis. For example,finger plates 4 can be biased away fromocclusion block 9 by force exerted fromperistaltic tube 223 to urgefinger plates 4 away fromperistaltic tube 223 when not engaged bycamshaft 2. As such,camshaft 2 can be configured to engageflat edge 44 to engageperistaltic tube 223 and not engagearcuate edge 45. - The
cam shaft 2 is coupled to themotor 3 for rotation about a longitudinal axis of thecam shaft 2, and has at least one radially-outward projection 21 defining a helical engagement portion disposed along a length of the cam shaft. The plurality offinger plates 4 are disposed along the length of the cam shaft. Eachfinger plate 4 is mounted for movement in a transverse direction relative to the longitudinal axis of the cam shaft, and is in operative engagement with the helical engagement portion to move transversely between an extended position and a return position. The processor is in operative communication with theencoder 3 b to receive rotation data to determine an amount of rotation ofmotor 3. - As discussed further herein, one or more processors can determine an amount of rotation of
motor 3 and/orcam shaft 2. The processor can be in communication with one or more memories to store the rotation data fromencoder 3 b over time. Using the rotation data fromencoder 3 b, the processor can determine an amount of rotation of themotor 3 orcam shaft 2 over a certain period of time, for example to determine a motor velocity. A predetermined relationship between the rotation of themotor 3 orcam shaft 2 and a sequential movement offinger plates 4 resulting in an amount of beneficial agent dispensed can be utilized to determine an amount of beneficial agent dispensed using the amount of rotation of themotor 3 orcam shaft 2. Additionally or alternatively, the processor can be operative to activate themotor 3 for a certain period of time, for example by operating themotor 3 until a desired amount of beneficial agent has been dispensed. - According to another aspect of the disclosed subject matter, and further to the above, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a fluid drive component disposed proximate the receiving region, a main controller circuit board coupled to and configured to control the fluid drive component, and at least one secondary circuit board foldably joined to the main controller circuit board through a flexible substrate and disposed within the interior in a stacked relationship relative the main controller circuit board. A plurality of such secondary circuit boards can be provided, each joined to the main controller circuit board by a flexible substrate either directly or indirectly.
- For example, and as embodied herein, the at least one secondary circuit board can include a power source controller board coupled to a power source. The at least one secondary circuit board can include an occlusion sensor controller board coupled to an occlusion sensor. The at least one secondary circuit board can include a serial bus controller board. The serial bus controller board can include an electromagnetic compatibility component. The serial bus controller board can include a serial bus port disposed proximate an exterior wall of the pump housing and aligned with an aperture in the exterior wall.
- Furthermore, and as embodied herein, the at least one secondary circuit board can include a motor signal encoder coupled to the fluid drive component. The fluid drive component can be coupled to the motor signal encoder in a stacked relationship with the main controller circuit board. The at least one secondary circuit board can include a speaker, alone or with an audio amplifier. The at least one secondary circuit board can include a haptic actuator.
- In addition, and as embodied herein, the at least one secondary circuit board can include a display controller coupled to a display. The display can further include a liquid crystal display (LCD). The display can further include a flexible light transmission component in optical communication with the LCD. The at least one secondary circuit board can include an input controller. The input controller board can include a plurality of input buttons disposed proximate an exterior wall of the pump housing and aligned with corresponding apertures in the exterior wall. The pump housing can have an interior having a height within a range of 18.5 mm to 20 mm. The flexible substrate can include polyimide, copper-clad polyimide, polyether ether ketone, transparent conductive polyester film, or a combination thereof. The flexible substrate can have a thickness within a range of 95 μm to 192.5 μm.
- In accordance with this aspect of the disclosed subject matter, the apparatus and methods herein can include one or more of the features described above. For purpose of illustration and not limitation, with reference to
FIG. 9 , the pump assembly includes a pump printed circuit board (PCB)assembly 200 joined to pump components. Thepump PCB assembly 200 can include a maincontroller circuit board 202, which, for purpose of illustration and not limitation, can be configured as a rigid flex PCB assembly using known construction techniques as illustrated for example inFIG. 9 . A remainder of thePCB assembly 200 can articulate around maincontroller circuit board 202 atseveral flex sections 204 to allow the PCB to conform and fold to fit the enclosure. In this manner, several secondary or satellite boards can provide functionality for certain functions proximate their point of use. - For purpose of illustration and not limitation, and as embodied herein, a secondary circuit board can include
battery PCB assembly 206, which can provide reverse battery protection, fusing, and proper creepage or clearance to meet regulatory requirements as well as including abattery connection 208, e.g., springs, to join apower source 210, embodied herein asbatteries 210, to pumpPCB assembly 200. Occlusion sensing can be performed in the pump mechanism, as described further herein, and a secondary circuit board can include a dedicated occlusion sensingPCB assembly 212, which can provide, for purpose of illustration and not limitation, latch detection. Additionally or alternatively, and as embodied herein, a secondary board can include a serialbus PCB assembly 214, which can include EMC components and can provide a suitable mounting location for aserial bus connector 216, which can be any suitable connector for data bus communication, including but not limited to a USB connector. Furthermore, and as embodied herein, a secondary circuit board can include abutton PCB assembly 224, which can have buttons joined thereto and disposed on an exterior face of the pump housing to provide input from a user to thepump assembly 100. - Referring still to
FIG. 9 , pumpPCB assembly 200 can have various off-board components joined thereto. For purpose of illustration, and not limitation, pumpPCB assembly 200 can have amotor 3 with anencoder 3 a joined tomain controller board 202. Additionally or alternatively, pumpPCB assembly 200 can have adisplay 218, embodied herein as a liquid crystal display (LCD) with flexlight joined tomain controller board 202. As a further alternative, pumpPCB assembly 200 can have ahaptic actuator 220 and/or aspeaker 222 joined to maincontroller circuit board 202, for example to provide tactile or audible feedback to a user. The off-board components can be joined to pump PCB assembly by any suitable connection, including but not limited to rigid flex connection and/or discrete wire connections of suitable construction as known. - Referring now to
FIGS. 10A-10D , an exemplary physical layout ofpump PCB assembly 200 is shown, for purpose of illustration and not limitation. As shown for example inFIGS. 10A-10D , occlusion sensingPCB assembly 212, serialbus PCB assembly 214,haptic actuator 220 andbutton PCB assembly 224 each are joined to maincontroller circuit board 202 viarigid flex portions 204. For purpose of illustration, and not limitation, the exemplary physical layout ofpump PCB assembly 200 can allow pump PCB assembly to be utilized in a relatively low-profile enclosure having a reduced footprint and thickness. For example, and as embodied herein, pumpPCB assembly 200 can be assembled in an enclosure having a length within a range of 110 mm to 115 mm, a width within a range of 63 mm to 65.7 mm and a thickness within a range of 18.45 mm to 20 mm. - According to another aspect of the disclosed subject matter, and further to the aspects above, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a fluid drive component disposed proximate the receiving region, a display to provide visual feedback to the user, a plurality of input buttons disposed on the pump housing, a first processor coupled to the fluid drive component and the display and configured to reduce power to or otherwise hibernate the fluid drive component and the display when the pump is in an inactive state, and a second processor coupled to the first processor and the plurality of input buttons. The second processor is configured to provide an activation signal to the first processor when one or more of the plurality of input buttons is deployed.
- Additionally or alternatively, the pump assembly can further include a radio-frequency identification (RFID) transceiver coupled to the first processor, and the first processor can be is configured to reduce power to the RFID transceiver when the pump is in the inactive state. The pump assembly can further include an occlusion sensor coupled to the first processor, and the first processor can be configured to reduce power to the occlusion sensor when the pump is in the inactive state.
- Furthermore, and as embodied herein, the pump assembly can further include a serial bus coupled to the first processor, and the first processor can be configured to reduce power to the serial bus when the pump is in the inactive state. The pump assembly can further include a power supply voltage monitor coupled to the second processor, and the second processor can be configured to maintain the power supply voltage monitor in an active state when the first processor is powered down. The pump assembly can further include one or more memories, a primary power supply and a backup power supply coupled to the second processor, and the second processor can be configured to utilize the backup power supply to save present data to the one or more memories when the second processor detects the primary power supply is removed or disabled.
- In addition, and as embodied herein, the pump assembly can further include a battery coulomb counter coupled to the second processor, and the second processor can be configured to maintain the battery coulomb counter in an active state when the first processor is powered down. The pump assembly can further include a speaker, and the first processor and the second processor each can be coupled to the speaker and configured to send an audio signal to the speaker when a fault is detected.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube and a pump. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly and has a receiving region to receive the cassette base region. The pump assembly includes a primary power source, a secondary power source coupled to the primary power source, a fluid drive component disposed proximate the receiving region and coupled to the primary power source isolated from the secondary power source, a first processor coupled to the primary power source and the secondary power source, a second processor coupled to the first processor, the primary power source and the secondary power source, one or more memories coupled to the first processor. At least one of the first processor and the second processor is configured, when the primary power source is removed or disabled, to utilize the secondary power source and the first processor to complete writing operations to the one or more memories prior to depletion of the secondary power source.
- Additionally, and as embodied herein, the secondary power source can include a 1F capacitor. The secondary power source can be coupled to the primary power source via a secondary power source charger configured to charge the secondary power source when the primary power source is active. The one or more memories can include a nonvolatile memory storage.
- Furthermore, and as embodied herein, the pump assembly can further include an RFID transceiver coupled to the secondary power source. The pump assembly can further include a speaker coupled to the secondary power source. The first processor and the second processor each can be coupled to the speaker, directly or via an audio amplifier, and configured to send an audio signal to the speaker when a fault is detected. The pump assembly can further include a display to provide visual feedback to the user. The display can be coupled to the primary power source and isolated from or otherwise not connected to the secondary power source. The pump assembly can further include an occlusion sensor coupled to the primary power source and isolated from the secondary power source.
- In accordance with these aspects, the pump assembly and related features as described above can be included individually or in combination. Referring now to
FIGS. 11A-11B , a block diagram of anexemplary delivery system 300 is illustrated. For purpose of illustration and not limitation, aprimary power source 302 provides power to thepump assembly 100.Primary power source 302 can be any suitable power source, and as embodied herein is a pair of series connected AA batteries. Apower supply system 304 provides appropriate voltages for the digital and analog functions of thepump assembly 100. Thepower supply system 302 can include mitigations for electromagnetic compatibility (EMC) events and circuitry to allow for segmentation of thepower supply system 304, which can improve battery life performance. - With reference to
FIGS. 11A-11B , a system of processor components can provide overall control of the system. One of ordinary skill in the art will appreciate that any of the system can be implemented using one or more processors configured to perform the techniques described herein. For example, a software application can be stored on a non-transitory computer readable medium, such as a CD-ROM, DVD, Magnetic disk, ROM, RAM, or the like, the instructions of which can be read into a memory coupled to the one or more processors of the system. When executed, the software can instruct the processor to perform a particular function. As described herein below, for purposes of clarity, functionality of the system may be described generally, without recitation that one or more processor of the system is configured to perform the functionality. Alternatively, the system can be implemented in hard-wired circuitry in place of, or in combination with, software instructions for implementation of the presently disclosed subject matter. Thus, embodiments of the presently disclosed subject matter are not limited to any specific combination of hardware and software, provided such hardware and software are configured to perform the method as disclosed herein. - For purpose of illustration and not limitation, with reference to
FIGS. 11A-11B , afirst processor 306 can be configured to provide motor control and UI functions. For example, and as embodied herein,first processor 306 can be configured as an ARM-based processor, such as a Texas Instruments Tiva processor, or any other suitable processor. Thefirst processor 306 can be configured to hibernate, i.e., to enter an inactive state for example to utilize less power when certain pump functions are not necessary or desired, and asecond processor 308 can be configured to perform certain background tasks whilefirst processor 306 hibernates. For example, and as embodied herein,second processor 308 can be configured as a mixed-signal microcontroller, such as a Texas Instruments MSP430, or any other suitable processor. Additionally, and as embodied herein, a number of sensing components can be operably coupled tofirst processor 306 and/orsecond processor 308, for example and without limitation, to sense occlusion, battery voltage and current, and communicate with an RFID tag in a beneficial agent container, as discussed further herein. - For purpose of illustration and not limitation, as embodied herein,
motor control system 300 includes amotor drive 310 configured to provide amplification ofmotor control output 312 fromfirst processor 306 to drivemotor 3, embodied herein as a brush DC motor coupled through a gearbox to the remainder ofpump assembly 100. Feedback fromencoder 3 a can be conditioned, for purpose of illustration and not limitation in the motor drive block, to allow for closed loop control of motor velocity and position, as shown for example inFIGS. 11A-11B . - Additionally, as embodied herein,
motor control system 300 can include a number of user interface (UI) components in communication withfirst processor 306 and/orsecond processor 308. UI components can include, for purpose of illustration and not limitation,display 218, embodied herein as an LCD display,speaker 222, embodied herein as a piezo ceramic speaker, and/or ahaptic actuator 220, configured to provide visual, audible and tactile feedback to a user, as discussed further herein. - Referring now to
FIGS. 12A-12B , an exemplary block diagram of apower supply system 304 is illustrated. For purpose of illustration and not limitation, as embodied herein,power supply system 304 includes asecondary power source 314.Secondary power source 314 can be any suitable power source, and as embodied herein is a pair of 1F capacitors.Power supply system 304 can be divided into two subsets of power supplies, for example and without limitation as illustrated by the dashed line ofFIGS. 12A-12B , including a first power subset 316 (e.g., right of dashed line) configured to receive backup power fromsecondary power source 314 whenprimary power source 302 is removed or disabled, e.g., upon failure or depletion thereof, and a second power subset 318 (e.g., left of the dashed line) configured to lose power upon removal or disabling ofprimary power source 302. - For purpose of illustration and not limitation, as embodied herein,
power supply system 304 can provide backup of digital hardware power supplies, for example and without limitation to allow for cleanup and user notification activities to complete upon removal or disabling ofprimary power source 302. Asupercapacitor manager 320 can provide charging control, balancing, and protection to thesecondary power source 314. For purpose of illustration, upon removal or disabling ofprimary power source 302, the supercapacitor manager can switchfirst power subset 316 to receive power fromsecondary power source 314. For example, can provide backup power to certain digital circuitry operating in a mid/high power state for a period of time until depletion ofsecondary power source 314, and as embodied herein, the period of time can be approximately 4 seconds. For example, and as embodied herein,power supply system 304 can provide backup power to a removablenon-volatile memory storage 322, such as a secure digital memory card, to allow for storage of files onmemory storage 322. As such, ifprimary power source 302 is removed or becomes disabled during a writing process tomemory storage 322, sufficient time can be provided bysecondary power source 314 to ensure internal processes of thememory storage 322 complete beforesecondary power source 314 fails. Additionally or alternatively, and as embodied herein, a Swissbit power fault tolerant SD card can be utilized inmemory storage 322 to reduce or prevent hard failures of the filesystem in the event of removal or disabling ofprimary power source 302. - Additionally, and as embodied herein,
power supply system 304 includes a number of power supplies to provide, for purpose of illustration and not limitation, appropriate voltage levels, references, and division of noisy and clean power. A first power path for the system can be derived from a first power supply 3V3_FG. As embodied herein, first power supply 3V3_FG can be implemented with a buck/boost low standby current supply to allow forprimary power supply 302 input voltages between 1.8 and ˜3.5V, which can represent a suitable range of input voltages provided by AA batteries, including without limitation, alkaline and Lithium Iron Disulfide cell batteries. First power supply 3V3_FG can supply power to, for example and without limitation,supercapacitor manager 320 and fuel gauging circuits, including acoulomb counter 324.Supercap manager 320 can provide a second power supply 3V3_DIG, which can represent a main power supply for all digital circuitry. -
Power supply system 304 can include a third power supply 3V3_M, which can be a 3.3V power supply configured to provide noise isolation tomotor drive 310. Third power supply 3V3_M can utilize a similar regulator as first power supply 3V3_FG, and as embodied herein, can be controlled bysecond processor 306 to allow independent shutdown of power supply tomotor 3, for example and without limitation to prevent or mitigate uncommanded motor operation. - Additionally or alternatively, and as embodied herein, a fourth power supply 5V0 can be derived from first power supply 3V3_FG, and can be configured to provide power to, for purpose of illustration and not limitation, analog sensors and
display 218, as discussed further herein. - Furthermore, and as embodied herein, a plurality of power segments can be included in one or more of the power supplies described herein. For example and without limitation, as embodied herein, the second power supply 3V3_DIG and fourth power supply 5V0 domains can each include a plurality of power segments to reduce or inhibit power used by individual peripherals. That is, certain peripherals of
pump assembly 100 do not allow for appropriately low power consumption when disabled. Thus, such high loss peripherals can be segmented behind, for example and without limitation, load switches. Other peripherals, for example and without limitation peripherals having an acceptably low loss, can be attached to their “parent” power supply rail, e.g., first power supply 3V3_FG or fourth power supply 5V0, as appropriate, and controlled by an appropriate enable signal. - For example and not limitation, as embodied herein, power segments can include a first supply segment 3V3_SD for the
memory storage 322 and second supply segment 3V3_USB for the serial bus 214 (shown for example inFIG. 11A ), each implemented from second power supply 3V3_DIG. Additionally or alternatively, as embodied herein, a third supply segment 5V0_HUNGRY can be provided to power theencoder 3 a andocclusion sensor 212, and can be implemented from fourth power supply 5V0, as shown for example inFIGS. 12A-12B . - In addition, and as embodied herein,
motor 3 can be powered bymotor drive 310, configured for example and as embodied herein as a single switch buck style motor drive. As embodied herein, motor inductance and back EMF can maintain supply currents tomotor 3 within an acceptable level. As such,motor 3 can be prevented or inhibited from receiving a reversed supply voltage, for example and without limitation due to certain failures (e.g., short or open) of any parts ofmotor drive 310, thus preventingmotor 3 from operating in reverse. - Referring now to
FIG. 13 , an exemplary fluiddrive control system 400 forpump assembly 100 is illustrated. As described further herein, as embodied herein,pump assembly 100 can be implemented as a linear peristaltic pump.Pump assembly 100 can include, as described herein, amotor 3 withencoder 3 a and gearbox mated to the components interface with theperistaltic tube 223, includingcam shaft 2 andfinger plates 4. In operation,pump assembly 100 can urge fluid through a tubing system joined toperistaltic tube 223 by engagingperistaltic tube 223 in a linear fashion from inlet to outlet, which can provide an inherent pinch valve function preventing the fluid moving from outlet to inlet. - For purpose of illustration and not limitation,
motor 3 can be anysuitable motor 3, for example and embodied herein as a cordless DC brushed motor. The windings ofmotor 3 can be selected having a size suitable to provide a torque and speed profile to drive the linear peristaltic pump with the voltage provided by the two AA batteries. For example and without limitation, as embodied herein,motor 3 can include suitable windings to provide a nominal terminal inductance of about 0.0354 mH. In operation,motor 3 provides rotational energy suitable to move thecam shaft 2 andfinger plates 4 to act upon the fluid in fluid communication withperistaltic tube 223. - Additionally, and as embodied herein,
gearbox 3 b can be disposed at the output ofmotor 3 and configured to translate torque provided frommotor 3 to provide higher torque tocam shaft 2 at the expense of lower output speed. For purpose of illustration, and as embodied herein,gearbox 3 b can have a gear ratio within a range between 67:1 and 131:1. Furthermore, and as embodied herein,bevel gears 6 can provide a 1:1 translation of torque and speed from the output ofgearbox 3 b tocam shaft 2. As such,motor 3 andgearbox 3 b can be oriented 90 degrees relative tocam shaft 2 to allow these components to fit within the desired enclosure. - With continued reference to
FIG. 13 , as embodied herein, a motor control loop and motor drive signal can be implemented to utilize one or more processors. For purpose of illustration, and not limitation, as embodied herein, the motor control loop and motor drive signal each can be implemented to utilizefirst processor 306. - For example, and as embodied herein, an exemplary technique for a
motor control loop 500 is illustrated inFIG. 14 . Referring now toFIG. 14 , in operation,motor control loop 500 can receive electrical pulses fromencoder 3 a asmotor 3 rotates. The electrical pulses fromencoder 3 a can be analyzed byfirst processor 306 to determine a change of position, at 501, ofmotor 3 by counting a total number of pulses and to determine a velocity, at 502, by measuring an amount of time between pulses. The calculated position and velocity information can thus provide inputs to themotor control loop 500. - With continued reference to
FIG. 14 , for purpose of illustration and not limitation, as embodied herein, two proportional integration (PI) controllers can be utilized: aposition PI controller 503 and avelocity PI controller 504. The calculated velocity can be input thereto. For example and not limitation, the input can be a trapezoid velocity profile, as illustrated herein. The present run duration and the present current position and velocity information can be updated based on theposition feedback 501 and thevelocity feedback 502 at regular intervals. For example and not limitation, as embodied herein, the regular intervals can be chosen as 1 millisecond. The present run duration can be compared to the determined run duration to determine whether the present run duration has exceeded the determined run duration. If the present run duration is exceeded,motor 3 can be stopped. A present position error can be calculated, which can be represented as a difference between the present run duration and the determined run duration. To continue driving the ramp up of the trapezoid profile, position PI controller can adjust for the position error to include the present position error, e.g., by decreasing the duration of the driving signal corresponding to the amount of the present run duration exceeding the determined run duration or by increasing the duration of the driving signal corresponding to the amount of the determined run duration that is less than the present run duration. Next the velocity error can be calculated, and the velocity PI controller can correct for the velocity error in a similar manner as the position error. The output from the velocity PI controller can be checked for saturation. The updated driving voltage can be outputted to themotor 3. - The inset of
FIG. 14 shows an exemplary trapezoidal velocity profile. For purpose of illustration and not limitation, an exemplary calculation for the trapezoidal velocity profile for a volume setpoint VSP of 25 μL can be performed as follows. The volume per revolution RPUMP of thecamshaft 2 of thepump assembly 100 can be a known constant based on camshaft design, for example and without limitation, as embodied herein 18 μL/rev. The gear ratio G betweenmotor 3 andcam shaft 2 can also be a known constant based on the motor and pump design, for example and without limitation, embodied herein as chosen within a range of 67:1 to 131:1. The volume per revolution of the motor RMOTOR can be represented as RPUMP/G=0.280597015 μL/rev. The number of revolutions of the motor TSP to deliver the volume set point can be represented as VSP/RMOTOR. A maximum velocity TDMAX can be selected based on the motor specification, for example and without limitation, embodied herein as 55.8 rev/s. The ramp up time tRU and ramp down time tRD each can be chosen based on the motor, and can be the same or different, for example and as embodied herein, each can be 0.1 s. The time tSS during which the motor is supplied with normal operating voltage corresponding to the max velocity can be represented as tSS=(TSP/TDMAX)−0.5*(tRU+tRD). Accordingly, a smaller volume setpoint can correspond to a smaller tSS. For example and not limitation, a volume setpoint of 1 μL can have a smaller tSS than described above. - Furthermore, and as embodied herein, the output of the
motor control loop 500, at 505, can provide a signal used to generate a pulse-width-modulation (PWM) signal for themotor drive 310. The PWM can provide a lower resultant voltage tomotor 3 as a function of the PWM duty cycle. The motor speed can be proportional to voltage, so the motor speed (and as a result, position) can be changed based on PWM duty cycle. The duty cycle can be determined by the output of themotor control loop 500. In this manner, the PWM can provide a signal for themotor drive 310 to control the voltage being applied to the motor. - For purpose of illustration and not limitation, as embodied herein,
motor drive 310 can be operated to apply an initial operating signal (e.g., a voltage or current) tomotor 3. The initial operating signal can start the operation of the motor at a relatively low level, which can reduce or prevent strain on themotor 3 during activation.Motor drive 310 can be operated to increase a magnitude of the operating signal to themotor 3 up to a normal operating signal, which is greater than the initial operating signal. The magnitude of the operating signal can be increased, for example and without limitation, in a linear manner, a stepped manner with any number of steps between the initial operating signal and the normal operating signal, a gradual manner, an exponential manner, or any other suitable manner of increasing the operating signal from the initial operating signal to the normal operating signal. - In addition, and as embodied herein,
motor drive 310 can receive the PWM signal provided fromfirst processor 306 to control the operating signal applied to themotor 3.Motor drive 310, for purpose of illustration and not limitation, can be implemented as a power MOSFET, which can be controlled by the PWM signal and switch on/off the operating signal applied tomotor 3. In this manner,motor drive 310 can convert battery energy to the desired operating signal formotor 3 to maintain suitable control of velocity and position ofmotor 3. -
Motor 3 can be driven to operate thepump assembly 100 in a manner to improve battery life. For purpose of illustration and not limitation, as embodied herein,motor 3 can be operated in bursts at higher speed, compared to continuous operation at low speeds. As such, themotor 3 can operated at a cadence, e.g., by performing a pumping event at a selected time interval. A processor can control themotor assembly 3, as described herein. For example and not limitation,processor 306 can causemotor drive 310 to apply an increasing magnitude of operating signal (e.g., voltage or current) tomotor 3 from an initial operating signal magnitude up to a normal operating signal magnitude, as described herein. Additionally, the processor can causemotor drive 310 to apply a decreasing magnitude of operating signal tomotor 3 from the normal operating signal magnitude back down to the initial operating signal magnitude. The operating signal magnitude can be increased or decreased, for example and without limitation, in a linear manner, a stepped manner with any number of steps between the initial magnitude and the normal operating magnitude, a gradual manner, an exponential manner, or any other suitable manner, as described herein. For purpose of illustration and not limitation, as embodied herein, the applied signal magnitude can correspond to a trapezoidal velocity profile of themotor 3. Additionally, as described herein,processor 306 can control themotor assembly 3 based on various input and/or feedback signals. For example, the input and/or feedback signals can include the position, velocity, and/or current of themotor assembly 3, as described herein. - For example and not limitation, the selected time interval for the cadence can be any suitable time period, for example and without limitation, selected between 1-15 minutes. Any suitable technique can be utilized to determine the appropriate operating time for each time interval to achieve a desired flow rate. For example, and as embodied herein, a lookup table can be used to determine an operating time for each time interval to achieve a selected flow rate. Alternatively, the cadence or operating time can be calculated based on a formula or other suitable technique. For purpose of illustration and not limitation, a base packet size can be selected to correspond to a base amount of fluid to be dispensed. For example, the base packet size can be any suitable volume, such as 1 μL, 12.5 μL, or 25 μL. A lookup table can provide fluid amounts, which can correspond to integer multiples of the base packet size being delivered at a selected time interval, embodied herein as a 1-minute time interval. For illustration and not limitation, a flow rate of 0.1 ml/h corresponds to one 25 μL packet every 15 minutes during the hour, 0.2 ml/h corresponds to one packet every eight minutes plus one extra packet during the hour (e.g. at the last minute 0), 0.3 ml/h corresponds to one packet every five minutes, etc. For example and not limitation, a pumping cadence for a flow rate of 0.6 mL/hr can be calculated as follows. 0.6 ml·hr can be equivalent to 600 μL/hr. Assuming an exemplary packet size of 25 μL, 600/25=24 packets to be delivered to achieve the flow rate. 24 packets divided over 60 minutes yields 2.5 minutes per packet. Rounding to the nearest whole number results in 3 minutes per packet, which yields 20 packets over the hour. The remaining 4 packets divided over 60 minutes results in 15 minutes per packet. The resulting cadence therefore can be one packet every 3 minutes and one additional packet every 15 minutes.
-
FIG. 15 is a diagram illustrating exemplary techniques for delivery of a beneficial agent to a user. At 2401, a flow rate is selected. Next, at 2402, a pumping cadence is determined based on flow rate. For example and not limitation, the pumping cadence can be calculated or can be determined from a lookup table accessible, as embodied herein byfirst processor 306, and additionally or alternatively bysecond processor 308. At 2403, a volume setpoint for a pumping event is determined for each time interval. For example, the volume setpoint can be calculated or looked up e.g., in a database or lookup table. At 2404, a number of motor revolutions corresponding to the volume setpoint can be calculated. For example, the number of motor revolutions can be determined from on a known ratio of revolutions to volume delivered. At 2405, a duration to activate themotor 3 to achieve motor revolutions can be calculated. For example, the duration for activating themotor 3 can be determined from a known motor velocity to achieve the number of determined motor revolutions. At 2406, the control loop, timers, and interrupts can be primed with results from the determined velocity and duration. Then at 2406, the control loop, timers, and interrupts can be enabled to activate themotor 3 at the determined velocity and duration. For each time interval, any suitable combination of the aforementioned events can be repeated to update the determined values for the time interval and to produce or adjust the motor control loop. - According to another aspect of the disclosed subject matter, and further to the above, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump, a lock member, and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, the pump housing having a receiving region to receive the cassette base region, the fluid drive component disposed proximate the receiving region. The lock member is coupled to the pump housing and movable between an open position and a closed position, the cassette capable of being inserted into and removed from the receiving region when the lock member is in the open position, and the cassette being secured to the pump with the cassette base region within the receiving region and a length of the delivery tube in operative engagement with the fluid drive component when the lock member is in the closed position. The lock member includes a proximity tag configured to be disposed proximate the proximity sensor when the lock member is in the closed position. The contact force sensor is in communication with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device further includes one or more processors in communication with the proximity sensor and the contact force sensor to receive a proximity signal and contact force data, respectively, therefrom, the one or more processors configured to determine whether the lock member is in the closed position using the proximity signal, determine whether the delivery tube is in operative engagement with the fluid drive component using the contact force data; and enable operation of the fluid drive component if the lock member is determined to be in the closed position and the delivery tube is determined to be in operative engagement with the fluid drive component.
- Additionally, and as embodied herein, the proximity sensor can include a reed switch. The proximity tag can include a magnet. The one or more processors can be further configured to compare the contact force data to a threshold value, and determine the delivery tube is in operative engagement with the fluid drive component if the contact force data exceeds the threshold value. The one or more processors can be further configured to determine a local minimum force value detected by the contact force sensor during each revolution of each pumping cycle, and determine the delivery tube is in operative engagement with the fluid drive component if the local minimum force value exceeds the local maximum force value of a corresponding pump cycle by a local minimum threshold amount.
- Furthermore, and as embodied herein, a cassette base region can include a RFID tag. The receiving region can include a RFID reader configured to read the RFID tag when the cassette is secured to the pump. The one or more processors can be further configured to receive identification information for the cassette encoded on the RFID tag from the RFID reader, determine whether the identification information is valid, and enable operation of the fluid drive component if the identification information is valid. The RFID tag can further include an expiration date of the beneficial agent, and the one or more processors can be further configured to receive the expiration date of the beneficial agent from the RFID reader, determine whether the expiration date is exceeded, and enable operation of the fluid drive component if the expiration date is not exceeded. The RFID tag can include high or ultra-high radio frequency ID.
- According to another aspect of the disclosed subject matter, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump, a lock member, and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region including a RFID tag. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, a proximity sensor and a RFID reader, the pump housing having a receiving region to receive the cassette base region, the fluid drive component, proximity sensor and RFID reader disposed proximate the receiving region. The lock member is coupled to the pump housing and movable between an open position and a closed position, the cassette capable of being inserted into and removed from the receiving region when the lock member is in the open position, and the cassette being secured to the pump with the cassette base region within the receiving region and a length of the delivery tube in operative engagement with the fluid drive component when the lock member is in the closed position. The lock member includes a proximity tag configured to be disposed proximate the proximity sensor when the lock member is in the closed position. The contact force sensor is in communication with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device further includes one or more processors in communication with the proximity sensor, the contact force sensor and the RFID reader to receive a proximity signal, contact force data and identification information for the cassette encoded on the RFID tag, respectively, therefrom, the one or more processors configured to determine whether the lock member is in the closed position using the proximity signal, determine whether the delivery tube is in operative engagement with the fluid drive component using the contact force data, determine whether the identification information is valid, and enable operation of the fluid drive component if the lock member is determined to be in the closed position, the delivery tube is determined to be in operative engagement with the fluid drive component, and the identification information is determined to be valid.
- Furthermore, and as embodied herein, the one or more processors can be further configured to receive identification information for the cassette encoded on the RFID tag from the RFID reader, determine whether the identification information is valid, and enable operation of the fluid drive component if the identification information is valid. The RFID tag can further include an expiration date of the beneficial agent, and the one or more processors can be further configured to receive the expiration date of the beneficial agent from the RFID reader, determine whether the expiration date is exceeded, and enable operation of the fluid drive component if the expiration date is not exceeded. The RFID tag can include high or ultra-high radio frequency ID.
- Each of these aspects can be combined with one or more of the various features of the apparatus and method described above. For purpose of illustration and not limitation, as embodied herein,
pump assembly 100 can include one or more sensors to provide information regarding the operation of the pump. For example and without limitation,pump assembly 100 can include an occlusion sensor 90 (shown inFIG. 1B ). As embodied herein,occlusion sensor 90 can include a Honeywell silicon strain gauge configured to measure a force ofperistaltic tube 223 againstocclusion block 9.Occlusion sensor 90 can be coupled toocclusion board 212 to provide force data received byocclusion sensor 90 tofirst processor 306, as shown for example inFIGS. 11A-11B . For purpose of illustration and not limitation, as embodied herein,occlusion board 212 can include an amplifier in line withocclusion sensor 90 to converts the output ofocclusion sensor 90 to a single ended signal suitable for processing byfirst processor 306. As discussed further herein,first processor 306 can perform calculations using the output ofocclusion board 212 during operation of the fluid drive component to determine whether an occlusion is present in a tubing system in communication withperistaltic tube 223, as discussed further herein. - Additionally or alternatively, referring now to
FIGS. 1 , 2G and 2H, and as embodied herein,pump assembly 100 can include aproximity tag 22 disposed inrecess 91 oflock member 11 to activate aproximity sensor 92 disposed proximatetop cover 14. For purpose of illustration and not limitation, as embodied herein, theproximity sensor 92 can include a reed switch, andproximity tag 22 can include a magnet. As such, when thelock member 11 is in the closed position,proximity tag 22 can activate theproximity sensor 92 to send a signal tofirst processor 306 and/orsecond processor 308 that thelock member 11 is in the closed position indicating thatocclusion block 9 is in operative engagement withperistaltic tube 223. - Additionally or alternatively, with reference to FIGS. 9 and 11A-11B, as embodied herein,
pump assembly 100 can include anRFID reader 320 coupled to anRFID antenna 322 configured to read an RFID tag from a cassette joined to pumpassembly 100.RFID reader 320 can be configured to identify drug cartridges and read information encoded in an RFID tag in a cassette joined to pumpassembly 100. In this manner, the system can be used to deter counterfeiting drug cartridges. As embodied herein,RFID reader 320 can be coupled tofirst processor 306 to process data read byRFID reader 320. - For purpose of illustration and not limitation, the RFID tag can include identification information encoded thereon for a cassette joined to pump
assembly 100. As embodied herein, identification information can include a serial number or other identification number. As such, and as embodied herein,first processor 306 can determine that the serial number or other identification number is a valid, for example using a checksum formula or any other suitable technique to validate an identification number. Additionally or alternatively, the RFID tag can include attribute information of a beneficial agent contained in the fluid reservoir encoded thereon, which can include, without limitation, a formation date and/or an expiration date of the beneficial agent.First processor 306 can thus compare the formation date and/or the expiration date of the beneficial agent to the present date to determine whether the beneficial agent is expired.First processor 306 can further validate the entire set of data from the RFID tag, which can include the identification information, if provided, attribute information, if provided, and any other information encoded on the RFID tag, and validation for the entire set of data can be formed, for example and without limitation, using a single checksum. - Referring now to
FIGS. 16A-16B , one or more of theocclusion sensor 90,proximity tag 22 andRFID reader 320, if provided, can provide notification and confirmation of attachment of the cassette to thepump assembly 100. For purpose of illustration, and not limitation, as shown for example inFIG. 16A , anexemplary technique 1500 for activating a device to deliver a beneficial agent for a user is provided. At 1501,pump assembly 100 can determine whetherlock member 11 is in the closed position, for example and as embodied herein usingproximity tag 22 and theproximity sensor 92 as described herein. At 1502,pump assembly 100 can determine whetherperistaltic tube 223 is in operative engagement withocclusion block 9 of thepump assembly 100, for example and as embodied herein usingocclusion sensor 90. That is, for purpose of illustration and not limitation,first processor 306 can compare force data received fromocclusion sensor 90, as described above, to a threshold. For purpose of illustration and not limitation, and as embodied herein, force data can be received fromocclusion sensor 90 in units referred to herein as “counts,” which can be a magnitude of a discrete or continuous signal over time corresponding to a magnitude of force againstocclusion sensor 90. As embodied herein, the threshold can be within a range of 150 counts to 2500 counts, which can represent a force greater than 0 and less than or equal to the force applied by theperistaltic tube 223 to theocclusion block 9 when in operative engagement therewith. At 1504, if the lock member is determined to be in the closed position and theperistaltic tube 223 is determined to be in operative engagement withocclusion block 9,pump assembly 100 can activatemotor drive 310 to drivemotor 3, as described herein. - For purpose of illustration, and not limitation, as shown for example in
FIG. 16B , anotherexemplary technique 1550 for activating a device to deliver a beneficial agent for a user is provided. At 1551,pump assembly 100 can determine whetherlock member 11 is in the closed position, for example and as embodied herein usingproximity tag 22 and theproximity sensor 92 as described herein. At 1552,pump assembly 100 can determine whetherperistaltic tube 223 is in operative engagement withocclusion block 9 of thepump assembly 100, for example and as embodied herein usingocclusion sensor 90, as described herein. At 1553, cassette identification information can be read byRFID sensor 320, if provided, andfirst processor 306 can determine whether the cassette identification information is valid, as described herein. At 1554, if the lock member is determined to be in the closed position, theperistaltic tube 223 is determined to be in operative engagement withocclusion block 9, and the cassette identification information is determined to be valid,pump assembly 100 can activatemotor drive 310 to drivemotor 3, as described herein. - According to another aspect of the disclosed subject matter, and further to the above, a device for delivery of a beneficial agent to a user generally includes a cassette, a delivery tube, a pump and a contact force sensor. The cassette includes a cassette housing with a fluid reservoir defined therein. The cassette housing has a cassette base region. The delivery tube is fluidly coupled with the fluid reservoir. The pump includes a pump housing containing a pump assembly having a fluid drive component, the pump housing having a receiving region to receive the cassette base region, the fluid drive component disposed proximate the receiving region. The contact force sensor is in communication, such as by direct or indirect contact, with the delivery tube and arranged to measure a force or pressure in the delivery tube. The device includes one or more processors in communication with the contact force sensor to receive data representing the measured force or pressure from the contact force sensor, the one or more processors configured to determine a maximum force value detected by the contact force sensor during an initial pumping cycle, the maximum force value corresponding to a baseline maximum force value, obtain subsequent force values from the contact force sensor during each subsequent pumping cycle, and determine an occlusion is present if one or more of the subsequent force values exceed the baseline maximum force value by a threshold amount.
- Additionally, and as embodied herein, the one or more processors can be further configured to determine a subsequent maximum force value during the subsequent pumping cycle, and adjust the baseline maximum force value to the subsequent maximum force value if the subsequent maximum force value is less than the baseline maximum force value. The threshold amount can be about 10% of the baseline maximum force value.
- Furthermore, and as embodied herein, the one or more processors can be further configured to determine a local maximum force value during an initial pump revolution of each pump cycle, the local maximum force corresponding to a baseline local maximum force value, obtain a subsequent local force maximum during each subsequent pump revolution of each pump cycle, and determine an occlusion is present if one or more of the subsequent local force maxima exceeds the baseline local maximum force value by a local threshold amount. The local threshold amount can be about 13% of the baseline local maximum force value. The one or more processors can be further configured to determine the local maximum force value of each pump cycle when a flow rate of the fluid drive component is above a threshold flow rate. The threshold flow rate can be 10 mL/hr.
- Furthermore, and as embodied herein, the one or more processors can be further configured to determine a local minimum force value detected by the contact force sensor during each revolution of each pumping cycle, and determine an error is present if the local minimum force value does not exceed the local maximum force value of a corresponding pump cycle by a local minimum threshold amount. The error can include a mechanical failure of the fluid drive component. The error can include an occlusion signal circuitry failure. A duration of each pumping cycle can be determined at least in part by a flow rate of the fluid drive component.
- In addition, and as embodied herein, the device can further include a motor operatively coupled to the fluid drive component, and a rotational position sensor operatively coupled to the motor to determine a rotational position of the motor. The one or more processors can be further operatively coupled to the rotational position sensor, and the one or more processors can be further configured to determine each pump revolution from the rotational position sensor. The one or more processors can be further configured to stop the fluid drive component when the occlusion is determined to be present. The device can further include a display operatively coupled to the one or more processors, and the one or more processors can be further configured to display an error signal on the display when the occlusion is determined to be present. The contact force sensor can include a single contact force sensor. The one or more processors can be further configured to apply a four-sample moving average filter to the data representing the measured force or pressure from the contact force sensor.
- These aspects can be combined with one or more features of the apparatus and method described above. Furthermore, and for purpose of illustration and not limitation, as described herein, techniques for occlusion sensing can use
occlusion sensor 90 to measure a force ofperistaltic tube 223 againstocclusion block 9.Occlusion sensor 90 can be coupled toocclusion board 212 to provide force data received byocclusion sensor 90 tofirst processor 306, as shown for example inFIGS. 11A-11B . For purpose of illustration and not limitation,occlusion sensor 90 can include a contact force sensor, for example and embodied herein as a strain gauge, mounted directly ontopump base block 1 to contact the peristaltic tubing proximate the outlet side of the tubing at ornear occlusion block 9. Such a location can allow the sensor to monitor occlusions in a tubing system disposed betweenpump assembly 100 and the patient. Furthermore, and as embodied herein,first processor 306 can perform averaging on data received fromocclusion sensor 90, for example and without limitation to reduce data spikes or other anomalies due to noise. As embodied herein, four-sample moving average filtering can be performed on the data. - For purpose of illustration and not limitation, and as embodied herein, exemplary techniques for occlusion sensing can include a one or more threshold checks. A difference between a nominal pumping pressure and the occlusion pressure can be affected by loading variability, the viscosity of the drug, and the pump cadence (e g running at higher pump speeds for shorter durations), which can contribute to increases in the peak pressures of the pump pulses. Occlusion sensing techniques can also be utilized to detect and prevent or inhibit pressure in the tubing system from exceeding a threshold pressure for an extended period of time. Additionally, and as embodied herein, a plurality of sensing techniques can be performed in parallel using the same data from a single occlusion sensor, which can be referred to as a “layered” approach. Alternatively, a single technique for occlusion sensing can be performed. As a further alternative, a plurality of sensing techniques using a plurality of occlusion sensors can be performed, either sequentially or in parallel.
- Additionally, and as embodied herein, exemplary techniques for occlusion sensing can analyze an
occlusion sensor 90 force magnitude, referred to herein as “counts,” at various points in a given pumping cycle and/or can analyze occlusion sensor force data prior to thepump assembly 100 activating for starts for a subsequent pumping cycle. Exemplary techniques for occlusion can examine a difference between occlusion pump counts, and determine whether an occlusion is present, as described herein. For example and without limitation, if the difference between two counts is outside of a predetermined window or threshold, thepump assembly 100 can determine an occlusion to be present. For purpose of illustration and not limitation, as embodied herein, the predetermined window or threshold can be within a range of 81 counts to 138 counts, which can vary based at least in part on the present flow rate of the pump. - Furthermore, and as embodied herein, pressure peaks can be sensed, an initial variability can be adjusted for, and other non-occlusion events can be accounted for. Force against the wall of
peristaltic tube 223 or pressure within theperistaltic tube 223 can be measured after thepump assembly 100 turns off and a force delta can be calculated after measuring the force when thepump assembly 100 turns back on for the next cadence. For purpose of illustration and not limitation, the delta can be large during normal pump operation at least in part because the internal pressure of the tubing can decay when the pump is off. During an occlusion, the delta can be measurably smaller, at least in part because there can be little or no pressure decay. When an occlusion is detected, thepump assembly 100 can be shut off (e.g. by terminating voltage supply to the motor 3). Additionally, the user can be notified, for example, by a screen prompt or an audio alarm. - As embodied herein, a pumping cycle can refer to a portion of time during which pump
assembly 100 is delivering a beneficial agent. Referring now toFIGS. 17A-17M , exemplary techniques for occlusion sensing are illustrated.FIG. 17A is a diagram illustrating exemplary occlusion sensor counts over time forpump assembly 100 operating at a 1 mL/hr flow rate, with an occlusion introduced into the system at about 1500 seconds.FIG. 17B illustrates a zoomed-in portion of the time scale of the diagram ofFIG. 17A . As shown for example inFIG. 17B , an exemplary pumping cycle is illustrated between about 322 seconds and 323 seconds on the time scale. For purpose of illustration and comparison,FIG. 17C is a diagram illustrating exemplary occlusion sensor counts over time at a 40 mL/hr flow rate, with an occlusion introduced into the system at about 250 seconds.FIG. 17D illustrates a detailed portion of the time scale of the diagram ofFIG. 17C . As shown for example inFIG. 17D , an exemplary pumping cycle is illustrated between about 62 seconds and 92 seconds on the time scale. As such, the duration of a pumping cycle can increase as flow rate increases. - Additionally or alternatively, and as embodied herein, the occlusion sensor can determine a maximum force value detected during an initial pumping cycle, which can be used to establish a baseline maximum. For purpose of illustration and not limitation,
FIG. 17E is a diagram illustrating exemplary occlusion sensor counts over time forpump assembly 100 operating at a 5 mL/hr flow rate, with an occlusion introduced into the system at about 900 seconds.FIG. 17F illustrates a detailed portion of the time scale of the diagram ofFIG. 17E . For example and without limitation, as shown inFIG. 17F , a maximum counts value of about 2330 is identified at about 5 seconds, and can be established as the baseline maximum counts value. Force values detected during subsequent pumping cycles can be compared to the established baseline maximum. For purpose of illustration and not limitation, when the detected force values during subsequent pumping cycles exceed the baseline maximum by a certain percentage, embodied herein as 10%, the occlusion sensor can determine an occlusion to be present. The percentage threshold can be adjusted to detect occlusions with suitable accuracy while reducing or eliminating false positives. - For purpose of illustration and not limitation, as embodied herein, the baseline maximum can be adjusted at during subsequent pumping cycles. Adjustment of the baseline maximum can account for certain amounts of relaxation of the cassette components that can occur during use or variations between different cassettes. For purpose of illustration and comparison,
FIG. 17G illustrates exemplary counts values over time of four different cassettes, illustrating variation of force counts over time within each cassette and overall among the different cassettes. To adjust the baseline maximum, the maximum force value detected during the subsequent pumping cycle can be compared to the baseline maximum. If the maximum force value detected during the subsequent pumping cycle is less than the baseline maximum, the lower maximum force value can become the new baseline maximum, and the detection of force values can be repeated for a subsequent pumping cycle. The adjustment to the baseline maximum can account for a variety of factors, including drift of the tubing. If the maximum force value detected during the subsequent pumping cycle is greater than the baseline maximum, but less than the threshold to detect an occlusion, the current baseline maximum can be maintained, and detection of force values can be repeated for a subsequent pumping cycle. Additionally or alternatively, the baseline maximum can be adjusted to account for changes in flow rate. For purpose of illustration, if the flow rate increase is detected, for example due to a change of flow rate setting or due to delivery of a higher flow rate dose, such as a morning dose or extra dose, a subsequent pumping cycle can be used to establish a new baseline maximum to avoid a false occlusion from being detected. As a further alternative, if a flow rate decrease is detected, for example due to a change of flow rate setting or due to delivery of a lower flow rate dose, such as a normal dose occurring after a morning dose or extra dose, the new baseline maximum can be adjusted as described above in a manner similar to accounting for tubing drift. - Furthermore or as a further alternative, detection of occlusions existing prior to pumping can be performed. Such occlusions can cause pump to exceed suitable pressure for an extended amount of time, and the time to detect an occlusion before suitable pressure is exceeded can be less than that for occlusions developing during pumping. As such, detection of occlusions existing prior to pumping can involve examining force data per pump revolution, that is, for example and not limitation, by detecting local maxima for each pump revolution within a given pumping cycle.
- For example and not limitation,
FIG. 17H is a diagram illustrating exemplary occlusion sensor counts over time forpump assembly 100 operating at a 40 mL/hr flow rate, with an occlusion introduced into the system at about 250 seconds. For purpose of illustration and comparison,FIG. 17I is a diagram illustrating exemplary pressure data from independent pressure sensor data corresponding to thepump assembly 100 operation ofFIG. 17H . As shown inFIG. 17I , a first pressure sensor 439058 is disposed on the cassette housing, and a second pressure sensor 439776 is disposed at a connection between the tubing system joined to the cassette and a patient administration set tubing. - Additionally, for purpose of illustration, and not limitation,
FIG. 17J illustrates a detailed portion of the time scale of the diagram ofFIG. 17H . As shown inFIG. 17J , for example and without limitation, a single pump revolution can be detected within a pumping cycle. Additionally or alternatively, a single pump revolution can be detected, for example and as embodied herein using motor rotation data fromencoder 3 b. As embodied herein, a maximum force during the single pump revolution can be detected and established as a reference maximum. For purpose of illustration, as embodied herein, a pump revolution after the initial pump revolution can be the single pump revolution to establish the reference maximum, for example and without limitation the third pump revolution after an initial pump revolution can be used to avoid initial pumping behavior, which can mimic a preexisting occlusion, affecting the established reference. For each subsequent pump revolution after the established reference, a maximum force can be detected and compared to the reference maximum. For purpose of illustration, and not limitation,FIG. 17K is a diagram illustrating exemplary occlusion sensor counts over time forpump assembly 100 operating at a 40 mL/hr flow rate. As shown inFIG. 17K , maximum and minimum forces for each pump revolution are identified with dots on the exemplary waveform. For purpose of illustration, and not limitation,FIG. 17L is a diagram illustrating further exemplary occlusion sensor counts over time forpump assembly 100 operating at a 40 mL/hr flow rate. As shown inFIG. 17L , a reference maximum (referred to as a reference counts value) is identified and compared to maximum force counts values for subsequent pump revolutions. For purpose of illustration and not limitation, when the detected maximum force exceeds the reference maximum by a certain percentage, which can be chosen for example and without limitation within a range of 13% to 55%, and as embodied herein can be 55%, the occlusion sensor can determine an occlusion to be present. The percentage threshold can be adjusted to detect occlusions with suitable accuracy while reducing or eliminating false positives. The occlusion sensor can be configured to examine local force maxima for detection of occlusions only when the flow rate is above a certain flow rate, for example and without limitation, embodied herein at 10 mL/hr. Lower flow rates can provide additional time to detect an occlusion using other techniques without examining the local force maxima during each pump revolution. Additionally or alternatively, for purpose of illustration, the occlusion sensor can be configured to examine local force maxima for detection of occlusions only for a predetermined number of pump revolutions, for example and embodied herein as nine pump revolutions, after an initial pump revolution during fluid delivery. As a further alternative, the local force minima and maxima can be adjusted as described above with respect to the baseline maximum for a pumping cycle, for example and without limitation to account for changes in flow rate, as described above. - In addition or as an additional alternative, detection of other failures can be performed by the occlusion sensor. For example and without limitation, as illustrated in
FIG. 17M , pump drivetrain failure (e.g., due to a broken camshaft or other drive train component) or occlusion sensor signal conditioning circuitry failure can produce a relatively flat force sensor waveform over time. As such, both minimum and maximum force can be determined for each pump revolution in a pumping cycle. As shown for example inFIG. 17M , if the maximum force does not exceed the minimum force by a certain threshold, the occlusion sensor can indicate an error. - According to another aspect of the disclosed subject matter, and further to the above, exemplary techniques for graphical user interfaces for a device for delivering a beneficial agent to a user are provided. For purpose of illustration and not limitation,
FIGS. 18A-1 to 18A-4 together are a schematic diagram illustratingexemplary techniques 1700 and associated graphical user interface screens for delivering a beneficial agent to a user. For example and without limitation, at 1701, a blank screen can be displayed ondisplay 218, indicating that the pump is not operational andfirst processor 306 is in a hibernation state. A user can press any input button in communication withbutton PCB assembly 224, as shown for example inFIGS. 11A-11B , to signalsecond processor 308 to awakenfirst processor 306 from a hibernation state to an active state and activatedisplay 218. At 1702, a splash screen ondisplay 218 can provide an indication to the user thatfirst processor 306 anddisplay 218 are active. At 1710, if a morning dose has not yet been delivered within a certain time period, thedisplay 218 can prompt a user to initiate a morning dose, as discussed further below. At 1703, if the morning dose has already been delivered within a certain time period, thedisplay 218 can prompt a user to initiate a normal dose. If the user selects to start normal delivery of a dose, at 1704,pump assembly 100 can be activated to deliver a dose for a predetermined flow rate, as described herein, and display 218 can provide a visual indication that the normal dose is being delivered. Thedisplay 218 can indicate, for purpose of illustration and not limitation, a remaining drug life time, a time until drug cartridge depletion, a flow rate, and an indication of the progress of the normal dose. At 1705, during delivery of the normal dose, a user can press an extra dose button to request an extra dose and can press a cancel button to cancel a dose. At 1706, if the user presses the extra dose button, and a number of extra doses exceeds a predetermined limit for a time period,display 218 can indicate that the extra dose option is locked out, and can further indicate when the option for an extra dose will become available. At 1707,display 218 indicates that the extra dose option is available. At 1708, if the user presses the extra dose button while it is available,pump assembly 100 can be activated to deliver a dose for a predetermined flow rate, as described herein, and display 218 can provide a visual indication that the normal dose is being delivered. - For purpose of illustration and not limitation,
FIG. 18B is a flow chart illustrating additional details of exemplary techniques to deliver a morning dose. For example and without limitation, as described above with respect to 1710, if a morning dose has not yet been delivered within a certain time period, thedisplay 218 can prompt a user to initiate a morning dose. To determine if a morning dose has been delivered, a morning dose lockout check can be performed. For example and without limitation, as embodied herein, when a morning dose is delivered at 1710, a morning dose lockout timer is set for a predetermined period of time, embodied herein as 18 hours. Additionally, as embodied herein, when a new cassette is detected, at 1712, a morning dose lockout check is performed. That is, at 1713, the morning dose lockout timer is checked to see if the lockout timer has expired and/or if a new cassette has been installed. If the lockout timer has not expired, or a new cassette has not been installed, the lockout check exits at 1717 and the user is prompted atscreen 1703 to start a normal dose. If the lockout timer has expired and a new cassette has been installed, at 1714, a morning dose icon is cleared fromdisplay 218. At 1715, an extra dose counter is reset to 0. At 1716, an existing event log file is closed and a new event log file is opened. The lockout check exits at 1717 and proceeds to 1710 to prompt the user to initiate a morning dose. - For purpose of illustration and not limitation,
FIGS. 18C-1 to 18C-2 and 18D-1 to 18D-4 are schematic diagrams illustrating additional details of exemplary techniques to allow a clinician to access settings forpump assembly 100. For example and without limitation, at 1721, a blank screen can be displayed ondisplay 218, indicating that the pump is not operational andfirst processor 306 is in a hibernation state, e.g., powered down. A clinician can press any input button in communication withbutton PCB assembly 224, as shown for example inFIGS. 11A-11B , to signalsecond processor 308 to awaken, e.g. activate,first processor 306 from a hibernation state to an active state and activatedisplay 218. At 1722, a splash screen ondisplay 218 can provide an indication to the clinician thatfirst processor 306 anddisplay 218 are active. Further at 1722, the clinician can press and hold a button, embodied herein as a bolus button, for a predetermined period of time to enter a code entry screen. At 1723, the clinician can be prompted to enter a clinician code to access menu options available to a clinician having the clinician code. At 1724, the clinician can select a clinician settings option to view and change a number of clinician settings. For purpose of illustration and not limitation, as embodied herein, clinician settings can include settings for high, medium and low flow rates that can be chosen by a patient, an extra dose flow rate, and a morning dose flow rate. At 1725, the clinician can select a patient settings option to view and change a number of settings for a patient. For purpose of illustration and not limitation, at 1726, patient settings can include a flow rate minimum, a flow rate maximum, and extra dose flow rate limit, and extra dose lockout period, a morning dose flow rate limit, and a morning dose lockout period. Additionally or alternatively, patient settings can include a morning dose enable/disable setting and/or an extra dose enable/disable. As embodied herein, if morning dose is disabled, the morning dose confirmation screens can be skipped. Additionally or alternatively, if extra dose is disabled, a notification screen can be displayed indicating the extra dose is disabled. - Each of the components described herein can be made of any suitable material (e.g., plastic, composites, metal, etc.) and technique for its intended purpose. In addition to the specific embodiments claimed below, the disclosed subject matter is also directed to other embodiments having any other possible combination of the dependent features claimed below and those disclosed above. As such, the particular features disclosed herein can be combined with each other in other manners within the scope of the disclosed subject matter such that the disclosed subject matter should be recognized as also specifically directed to other embodiments having any other possible combinations. Thus, the foregoing description of specific embodiments of the disclosed subject matter has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosed subject matter to those embodiments disclosed.
- The devices and techniques of the disclosed subject matter can be used for delivery of any of a variety of suitable fluid substances of corresponding volume or dose.
- While the disclosed subject matter is described herein in terms of certain preferred embodiments, those skilled in the art will recognize that various modifications and improvements can be made to the disclosed subject matter without departing from the scope thereof. Moreover, although individual features of one embodiment of the disclosed subject matter can be discussed herein or shown in the drawings of the one embodiment and not in other embodiments, it should be apparent that individual features of one embodiment can be combined with one or more features of another embodiment or features from a plurality of embodiments.
- In addition to the specific embodiments claimed below, the disclosed subject matter is also directed to other embodiments having any other possible combination of the dependent features claimed below and those disclosed above. As such, the particular features presented in the dependent claims and disclosed above can be combined with each other in other manners within the scope of the disclosed subject matter such that the disclosed subject matter should be recognized as also specifically directed to other embodiments having any other possible combinations. Thus, the foregoing description of specific embodiments of the disclosed subject matter has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the disclosed subject matter to those embodiments disclosed.
- It will be apparent to those skilled in the art that various modifications and variations can be made in the method and system of the disclosed subject matter without departing from the spirit or scope of the disclosed subject matter. Thus, it is intended that the disclosed subject matter include modifications and variations that are within the scope of the appended claims and their equivalents.
Claims (54)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/586,927 US20150182697A1 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
AU2014373703A AU2014373703B2 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for beneficial agent delivery |
JP2016543591A JP6702873B2 (en) | 2013-12-31 | 2014-12-31 | Pumps, motors and assemblies for delivery of beneficial agents |
PCT/US2014/072964 WO2015103377A2 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for beneficial agent delivery |
CA2935686A CA2935686A1 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for beneficial agent delivery |
EP14827699.1A EP3089772B1 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for beneficial agent delivery |
EP17203875.4A EP3308811A1 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for beneficial agent delivery |
ES14827699.1T ES2668987T3 (en) | 2013-12-31 | 2014-12-31 | Pump, motor and assembly for the supply of a beneficial agent |
BR112016015410A BR112016015410A2 (en) | 2013-12-31 | 2014-12-31 | PERISTALTIC PUMP AND DEVICE FOR DELIVERING A BENEFICIAL AGENT TO A USER |
US16/243,662 US20190143034A1 (en) | 2013-12-31 | 2019-01-09 | Pump, motor and assembly for beneficial agent delivery |
JP2020031258A JP6922015B2 (en) | 2013-12-31 | 2020-02-27 | Pumps, motors and assemblies for the delivery of beneficial drugs |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361922709P | 2013-12-31 | 2013-12-31 | |
US201462054134P | 2014-09-23 | 2014-09-23 | |
US14/586,927 US20150182697A1 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/243,662 Division US20190143034A1 (en) | 2013-12-31 | 2019-01-09 | Pump, motor and assembly for beneficial agent delivery |
Publications (1)
Publication Number | Publication Date |
---|---|
US20150182697A1 true US20150182697A1 (en) | 2015-07-02 |
Family
ID=53480602
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/586,927 Pending US20150182697A1 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
US14/586,923 Active 2036-01-03 US10232111B2 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
US14/586,930 Abandoned US20150182698A1 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
US16/243,662 Pending US20190143034A1 (en) | 2013-12-31 | 2019-01-09 | Pump, motor and assembly for beneficial agent delivery |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/586,923 Active 2036-01-03 US10232111B2 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
US14/586,930 Abandoned US20150182698A1 (en) | 2013-12-31 | 2014-12-30 | Pump, motor and assembly for beneficial agent delivery |
US16/243,662 Pending US20190143034A1 (en) | 2013-12-31 | 2019-01-09 | Pump, motor and assembly for beneficial agent delivery |
Country Status (8)
Country | Link |
---|---|
US (4) | US20150182697A1 (en) |
EP (2) | EP3308811A1 (en) |
JP (2) | JP6702873B2 (en) |
AU (1) | AU2014373703B2 (en) |
BR (1) | BR112016015410A2 (en) |
CA (1) | CA2935686A1 (en) |
ES (1) | ES2668987T3 (en) |
WO (1) | WO2015103377A2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109562222A (en) * | 2016-08-12 | 2019-04-02 | 赛诺菲-安万特德国有限公司 | Drug delivery device |
WO2020002386A1 (en) * | 2018-06-29 | 2020-01-02 | Koninklijke Philips N.V. | Ironless electric motor for mri compatibility |
US11020321B2 (en) * | 2014-10-15 | 2021-06-01 | Kpr U.S., Llc | Occlusion detection for flow control apparatus |
WO2021113057A1 (en) * | 2019-12-05 | 2021-06-10 | Hach Company | Peristaltic pump |
US11241530B1 (en) * | 2020-11-23 | 2022-02-08 | Amf Medical Sa | Insulin patch pump having photoplethysmography module |
US11529458B2 (en) | 2017-12-08 | 2022-12-20 | Amf Medical Sa | Drug delivery device |
US11529464B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Systems and methods for monitoring delivery of microdoses of medication |
US11679199B2 (en) | 2021-06-01 | 2023-06-20 | Amf Medical Sa | Systems and methods for delivering microdoses of medication |
US11806502B2 (en) | 2015-11-20 | 2023-11-07 | Tandem Diabetes Care Switzerland Sarl | Micropump |
US11857757B2 (en) | 2021-06-01 | 2024-01-02 | Tandem Diabetes Care Switzerland Sàrl | Systems and methods for delivering microdoses of medication |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3258995A4 (en) | 2015-02-20 | 2018-12-12 | Regeneron Pharmaceuticals, Inc. | Syringe systems, piston seal systems, stopper systems, and methods of use and assembly |
US20230123806A1 (en) | 2017-07-07 | 2023-04-20 | Neuroderm, Ltd. | Device for subcutaneous delivery of fluid medicament |
CN113274578B (en) | 2017-07-07 | 2022-06-03 | 纽罗德姆有限公司 | Device for subcutaneous delivery of fluid drugs |
CA3051543A1 (en) | 2018-08-30 | 2020-02-29 | Becton, Dickinson And Company | Liquid medicament reservoir empty detection sensor and occlusion sensor for medicament delivery device |
Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529401A (en) * | 1982-01-11 | 1985-07-16 | Cardiac Pacemakers, Inc. | Ambulatory infusion pump having programmable parameters |
US4562751A (en) * | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US5368562A (en) * | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
US5620312A (en) * | 1995-03-06 | 1997-04-15 | Sabratek Corporation | Infusion pump with dual-latching mechanism |
US6227203B1 (en) * | 1998-02-12 | 2001-05-08 | Medtronic, Inc. | Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion |
US20020016568A1 (en) * | 2000-01-21 | 2002-02-07 | Lebel Ronald J. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US20020193679A1 (en) * | 1998-04-29 | 2002-12-19 | Medtronic Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US20050090808A1 (en) * | 2003-04-30 | 2005-04-28 | Luis Malave | Multi-processor medical device |
US20070214872A1 (en) * | 2006-02-14 | 2007-09-20 | Mettler-Toledo Ag | Measuring device, measuring probe, and method of operating the measuring device |
US20090067989A1 (en) * | 2007-09-06 | 2009-03-12 | M2 Medical Group Holdings, Inc. | Occlusion Sensing System for Infusion Pumps |
US20090099505A1 (en) * | 2007-10-12 | 2009-04-16 | Animas Corporation | Data Transmission System For A Drug Infusion Device |
US20110190852A1 (en) * | 2010-02-03 | 2011-08-04 | Dinsmoor David A | Implantable medical devices and systems having dual frequency inductive telemetry and recharge |
US20110270219A1 (en) * | 2008-04-30 | 2011-11-03 | Roche Diagnostics International Ag | Administration device having a button with touch sensor |
Family Cites Families (162)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1708333A (en) | 1926-12-14 | 1929-04-09 | Iowa State College Of Agricult | Strain gauge |
GB369037A (en) | 1931-04-22 | 1932-03-17 | Yoshinobu Wada | Improvements in or relating to a pumping apparatus for medical treatments |
US1922196A (en) * | 1932-03-17 | 1933-08-15 | Nordberg Manufacturing Co | Pump |
FR1351597A (en) | 1962-12-28 | 1964-02-07 | Mecanique Metallurgie Ste Gle | Improvements to pumps |
GB1081818A (en) | 1965-03-05 | 1967-09-06 | Distillers Co Yeast Ltd | Improvements in or relating to flexible tube pumps |
US3603152A (en) | 1970-02-05 | 1971-09-07 | Columbia Research Lab Inc | Transducer for detecting pressure changes in fluid flow |
US3736930A (en) | 1970-04-14 | 1973-06-05 | Ivac Corp | Parenteral administration fluid flow control system |
US4370983A (en) | 1971-01-20 | 1983-02-01 | Lichtenstein Eric Stefan | Computer-control medical care system |
US3985467A (en) | 1975-05-27 | 1976-10-12 | Milton Roy Company | Constant pressure pump |
US4174637A (en) | 1978-10-19 | 1979-11-20 | International Business Machines Corporation | Pressure monitoring system |
JPS56113083A (en) | 1980-02-12 | 1981-09-05 | Terumo Corp | Choke detection method and device for peristaltic liquid pump |
US4394862A (en) | 1980-08-25 | 1983-07-26 | Baxter Travenol Laboratories, Inc. | Metering apparatus with downline pressure monitoring system |
US4460355A (en) | 1982-06-11 | 1984-07-17 | Ivac Corporation | Fluid pressure monitoring system |
US4493706A (en) | 1982-08-12 | 1985-01-15 | American Hospital Supply Corporation | Linear peristaltic pumping apparatus and disposable casette therefor |
US4482347A (en) | 1982-08-12 | 1984-11-13 | American Hospital Supply Corporation | Peristaltic fluid-pumping apparatus |
US4534756A (en) | 1983-04-11 | 1985-08-13 | Ivac Corporation | Fault detection apparatus and method for parenteral infusion system |
GB8312069D0 (en) | 1983-05-03 | 1983-06-08 | Peritronic Medical Ind Plc | Peristaltic pumps |
US4530696A (en) | 1983-06-13 | 1985-07-23 | Institute Of Critical Care Medicine | Monitor for intravenous injection system for detecting occlusion and/or infiltration |
US4657486A (en) * | 1984-01-13 | 1987-04-14 | Stempfle Julius E | Portable infusion device |
US4840542A (en) | 1985-03-27 | 1989-06-20 | Quest Medical, Inc. | Infusion pump with direct pressure sensing |
US4690673A (en) | 1985-11-26 | 1987-09-01 | Imed Corporation | Dual mode I.V. infusion device with distal sensor |
US4617014A (en) * | 1985-11-26 | 1986-10-14 | Warner-Lambert Company | Dual mode I. V. infusion device |
US4671792A (en) * | 1986-02-18 | 1987-06-09 | American Hospital Supply Corporation | Pressure-regulating peristaltic pump |
US4778451A (en) | 1986-03-04 | 1988-10-18 | Kamen Dean L | Flow control system using boyle's law |
US4898576A (en) | 1986-06-06 | 1990-02-06 | Philip James H | Intravenous fluid flow monitor |
US4710163A (en) | 1986-06-06 | 1987-12-01 | Ivac Corporation | Detection of fluid flow faults in the parenteral administration of fluids |
US4743228A (en) | 1986-08-18 | 1988-05-10 | Ivac Corporation | Fluid flow monitoring method and system |
US4882575A (en) | 1987-01-28 | 1989-11-21 | Sharp Kabushiki Kaisha | Monitor for blocked condition in tube for fluid infusion pump |
US4867744A (en) | 1987-05-21 | 1989-09-19 | Baxter International Inc. | Peristaltic linear pump with contoured rollers |
US4979940A (en) | 1988-03-08 | 1990-12-25 | Baxter International Inc. | Infusion system, methodology, and algorithm for identifying patient-induced pressure artifacts |
US5803712A (en) | 1988-05-17 | 1998-09-08 | Patient Solutions, Inc. | Method of measuring an occlusion in an infusion device with disposable elements |
JPH0511872Y2 (en) | 1988-11-30 | 1993-03-25 | ||
US5190522A (en) | 1989-01-20 | 1993-03-02 | Institute Of Biocybernetics And Biomedical Engineering P.A.S. | Device for monitoring the operation of a delivery system and the method of use thereof |
US5087245A (en) | 1989-03-13 | 1992-02-11 | Ivac Corporation | System and method for detecting abnormalities in intravascular infusion |
US5013535A (en) * | 1989-04-20 | 1991-05-07 | Uop | Stabilized aluminophosphate compositions and process for preparing same |
US5211548A (en) * | 1989-07-31 | 1993-05-18 | Terumo Kabushiki Kaisha | Peristaltic pump having a motor overload protector |
US4909710A (en) | 1989-10-23 | 1990-03-20 | Fisher Scientific Company | Linear peristaltic pump |
US5096385A (en) | 1989-11-08 | 1992-03-17 | Ivac Corporation | Method and system for upstream occlusion detection |
US4954046A (en) * | 1989-12-08 | 1990-09-04 | Imed Corporation | Peristaltic pump with mechanism for maintaining linear flow |
US5116203A (en) | 1990-03-15 | 1992-05-26 | Abbott Laboratories | Detecting occlusion of proximal or distal lines of an IV pump |
US5165874A (en) * | 1990-05-04 | 1992-11-24 | Block Medical, Inc. | Disposable infusion apparatus and peristaltic pump for use therewith |
US5092749A (en) | 1990-05-07 | 1992-03-03 | Imed Corporation | Fluid pump drive mechanism |
JPH0693916B2 (en) * | 1990-10-31 | 1994-11-24 | テルモ株式会社 | Infusion pump |
US5486286A (en) | 1991-04-19 | 1996-01-23 | Althin Medical, Inc. | Apparatus for performing a self-test of kidney dialysis membrane |
AU3329793A (en) | 1991-12-20 | 1993-07-28 | Abbott Laboratories | Infusion pump security system |
EP0554716B1 (en) | 1992-01-22 | 1997-12-03 | Alaris Medical Systems, Inc. | Fluid line condition detection |
DE9205733U1 (en) * | 1992-04-29 | 1993-09-02 | Magnus Gmbh | Peristaltic pump |
US5295967A (en) | 1992-09-23 | 1994-03-22 | Becton, Dickinson And Company | Syringe pump having continuous pressure monitoring and display |
US5242408A (en) | 1992-09-23 | 1993-09-07 | Becton, Dickinson And Company | Method and apparatus for determining pressure and detecting occlusions in a syringe pump |
US5354273A (en) | 1992-12-14 | 1994-10-11 | Mallinckrodt Medical, Inc. | Delivery apparatus with pressure controlled delivery |
US5336053A (en) | 1993-01-29 | 1994-08-09 | Abbott Laboratories | Method of testing for leakage in a solution pumping system |
US5292306A (en) | 1993-01-29 | 1994-03-08 | Abbott Laboratories | Method of detecting occlusions in a solution pumping system |
JPH0726911A (en) * | 1993-05-13 | 1995-01-27 | Sumitomo Electric Ind Ltd | Camshaft |
US5472420A (en) | 1993-06-03 | 1995-12-05 | Infusion Technologies Corporation | Valve system and method for control of an infusion pump |
FR2710537B1 (en) | 1993-09-30 | 1995-12-01 | Becton Dickinson Co | Method and device for detecting occlusions in a perfusion line. |
JP3320179B2 (en) * | 1993-12-17 | 2002-09-03 | シャープ株式会社 | Infusion pump |
US5482438A (en) * | 1994-03-09 | 1996-01-09 | Anderson; Robert L. | Magnetic detent and position detector for fluid pump motor |
GB9405523D0 (en) | 1994-03-21 | 1994-05-04 | Graseby Medical Ltd | Pumping and pressure detection using flexible tubes |
US5695473A (en) | 1994-07-27 | 1997-12-09 | Sims Deltec, Inc. | Occlusion detection system for an infusion pump |
US5511951A (en) | 1994-08-08 | 1996-04-30 | O'leary; Stephen H. | IV fluid delivery system |
US5549460A (en) | 1994-08-08 | 1996-08-27 | Ivac Corporation | IV fluid delivery system |
US5717603A (en) * | 1994-08-19 | 1998-02-10 | Spectrel Partners, L.L.C. | Integrated test station for testing liquid flow and electrical safety characteristics of IV pumps |
US5803917A (en) | 1994-09-13 | 1998-09-08 | Alaris Medical Systems, Inc. | Fluid flow resistance monitoring system |
US5609576A (en) | 1994-09-13 | 1997-03-11 | Ivac Medical Systems, Inc. | Fluid flow impedance monitoring system |
US5580221A (en) | 1994-10-05 | 1996-12-03 | Franklin Electric Co., Inc. | Motor drive circuit for pressure control of a pumping system |
JP3749277B2 (en) * | 1995-01-18 | 2006-02-22 | アラリス メディカル システムズ インコーポレイテッド | Infusion pump |
US5647853A (en) | 1995-03-03 | 1997-07-15 | Minimed Inc. | Rapid response occlusion detector for a medication infusion pump |
US5628619A (en) * | 1995-03-06 | 1997-05-13 | Sabratek Corporation | Infusion pump having power-saving modes |
US5827223A (en) | 1995-08-31 | 1998-10-27 | Alaris Medical Systems, Inc. | Upstream occulsion detection system |
JP3698277B2 (en) | 1995-11-28 | 2005-09-21 | テルモ株式会社 | Infusion pump |
US5791881A (en) | 1996-10-18 | 1998-08-11 | Moubayed; Ahmad-Maher | Curvilinear peristaltic pump with occlusion detection means |
US6158965A (en) | 1996-07-30 | 2000-12-12 | Alaris Medical Systems, Inc. | Fluid flow resistance monitoring system |
FR2753236B1 (en) * | 1996-09-10 | 1998-12-04 | Conseilray Sa | MINIATURE PERISTALTIC PUMP |
US5814009A (en) | 1996-10-11 | 1998-09-29 | Cabot Technology Corporation | Fluid management system and replaceable tubing assembly therefor |
US5906589A (en) | 1996-11-13 | 1999-05-25 | Cobe Laboratories, Inc. | Method and apparatus for occlusion monitoring using pressure waveform analysis |
GR1002892B (en) | 1997-02-17 | 1998-04-10 | Micrel | Linear peristaltic pump |
IL120651A (en) | 1997-04-11 | 2001-06-14 | Nestle Sa | Administration of liquid to a patient |
DE29724578U1 (en) | 1997-04-18 | 2002-03-28 | Nestle Sa | Peristaltic pump |
US5808203A (en) | 1997-05-12 | 1998-09-15 | Medrad, Inc. | Fluid pressure measurement devices |
US5964583A (en) * | 1997-10-15 | 1999-10-12 | Baxter International Inc. | Elastomerically assisted peristaltic pump |
CA2257027C (en) * | 1998-01-21 | 2009-12-22 | Jakob Van Dijk | A device for dosing powdered materials |
AUPP192098A0 (en) | 1998-02-19 | 1998-03-12 | University Of Melbourne, The | Linearised peristaltic pump |
US6200289B1 (en) | 1998-04-10 | 2001-03-13 | Milestone Scientific, Inc. | Pressure/force computer controlled drug delivery system and the like |
US5989222A (en) | 1998-06-12 | 1999-11-23 | Abbott Laboratories | Pressure (occlusion) sensor |
US6422057B1 (en) * | 1998-09-29 | 2002-07-23 | Deltec, Inc. | Drug pump testing system and methods |
US7621893B2 (en) | 1998-10-29 | 2009-11-24 | Medtronic Minimed, Inc. | Methods and apparatuses for detecting occlusions in an ambulatory infusion pump |
US7766873B2 (en) | 1998-10-29 | 2010-08-03 | Medtronic Minimed, Inc. | Method and apparatus for detecting occlusions in an ambulatory infusion pump |
US6164921A (en) | 1998-11-09 | 2000-12-26 | Moubayed; Ahmad Maher | Curvilinear peristaltic pump having insertable tubing assembly |
FR2790041B1 (en) | 1999-02-23 | 2002-01-18 | Fresenius Vial | METHOD FOR CONTROLLING A PUMPING DEVICE COMPRISING A PUMP PROVIDED WITH A FLEXIBLE TUBE AND DEVICE FOR IMPLEMENTING THE METHOD |
US6423035B1 (en) * | 1999-06-18 | 2002-07-23 | Animas Corporation | Infusion pump with a sealed drive mechanism and improved method of occlusion detection |
US6554791B1 (en) | 1999-09-29 | 2003-04-29 | Smisson-Cartledge Biomedical, Llc | Rapid infusion system |
US7255680B1 (en) | 1999-10-27 | 2007-08-14 | Cardinal Health 303, Inc. | Positive pressure infusion system having downstream resistance measurement capability |
US7169352B1 (en) | 1999-12-22 | 2007-01-30 | Gambro, Inc. | Extracorporeal blood processing methods and apparatus |
US6485465B2 (en) | 2000-03-29 | 2002-11-26 | Medtronic Minimed, Inc. | Methods, apparatuses, and uses for infusion pump fluid pressure and force detection |
AU2002211821A1 (en) * | 2000-09-27 | 2002-04-08 | Cobe Cardiovascular, Inc. | Disposable cartridge for a blood perfusion system |
US6572604B1 (en) | 2000-11-07 | 2003-06-03 | Baxter International Inc. | Occlusion detection method and system for ambulatory drug infusion pump |
US6620151B2 (en) | 2001-03-01 | 2003-09-16 | Advanced Neuromodulation Systems, Inc. | Non-constant pressure infusion pump |
US7264148B2 (en) | 2001-09-12 | 2007-09-04 | Terumo Kabushiki Kaisha | Drug container and drug infusion device comprising the same |
US20030088238A1 (en) | 2001-09-26 | 2003-05-08 | Poulsen Jens Ulrik | Modular drug delivery system |
US7291126B2 (en) | 2001-11-26 | 2007-11-06 | Nilimedix Ltd. | Drug delivery device and method |
US20030141981A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | System and method for operating medical devices |
US20030160698A1 (en) | 2002-02-26 | 2003-08-28 | Safety Syringes, Inc. | Systems and methods for tracking pharmaceuticals within a facility |
US7033338B2 (en) * | 2002-02-28 | 2006-04-25 | Smiths Medical Md, Inc. | Cartridge and rod for axially loading medication pump |
US8504179B2 (en) | 2002-02-28 | 2013-08-06 | Smiths Medical Asd, Inc. | Programmable medical infusion pump |
US7241115B2 (en) | 2002-03-01 | 2007-07-10 | Waters Investments Limited | Methods and apparatus for determining the presence or absence of a fluid leak |
US7278983B2 (en) * | 2002-07-24 | 2007-10-09 | Medtronic Minimed, Inc. | Physiological monitoring device for controlling a medication infusion device |
US20040051368A1 (en) | 2002-09-17 | 2004-03-18 | Jimmy Caputo | Systems and methods for programming pumps |
DE10246469A1 (en) * | 2002-10-04 | 2004-04-15 | Applica Gmbh | Pump with peristaltic drive for medical applications, has cam segments with defined ratio between lamella height and stroke |
US7104763B2 (en) | 2002-10-16 | 2006-09-12 | Abbott Laboratories | Method for discriminating between operating conditions in medical pump |
US7360999B2 (en) | 2002-10-16 | 2008-04-22 | Abbott Laboratories | Means for using single force sensor to supply all necessary information for determination of status of medical pump |
CA2522855A1 (en) | 2003-04-23 | 2004-11-04 | Vasogen Ireland Limited | Dispensing systems |
WO2004110524A2 (en) | 2003-06-06 | 2004-12-23 | Phacor, Inc. | Fluid-flow cassette for an ophthalmic surgical instrument |
US8182461B2 (en) | 2003-11-04 | 2012-05-22 | Smiths Medical Asd, Inc. | Syringe pump rapid occlusion detection system |
US8672875B2 (en) | 2003-12-31 | 2014-03-18 | Carefusion 303, Inc. | Medication safety enhancement for secondary infusion |
DE102004019053A1 (en) | 2004-04-20 | 2005-11-24 | Disetronic Licensing Ag | Apparatus and method for occlusion detection in infusion pumps |
SE0401842D0 (en) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
WO2006006643A1 (en) | 2004-07-14 | 2006-01-19 | Nemoto Kyorindo Co., Ltd. | Medical liquid injection system |
CA2622454C (en) | 2005-04-06 | 2012-07-10 | Mallinckrodt Inc. | Systems and methods for managing information relating to medical fluids and containers therefor |
US7472301B2 (en) * | 2005-05-27 | 2008-12-30 | Codman Neuro Sciences Sárl | Circuitry for optimization of power consumption in a system employing multiple electronic components, one of which is always powered on |
US7737581B2 (en) * | 2005-08-16 | 2010-06-15 | Medtronic Minimed, Inc. | Method and apparatus for predicting end of battery life |
CA2641569C (en) | 2006-02-09 | 2015-10-06 | Deka Products Limited Partnership | Fluid delivery systems and methods |
US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
WO2007123764A2 (en) | 2006-04-06 | 2007-11-01 | Medtronic, Inc. | Systems and methods of identifying catheter malfunctions using pressure sensing |
IL179229A0 (en) | 2006-11-13 | 2007-03-08 | Q Core Ltd | Magnetically balanced finger-type peristaltic pump |
US8535025B2 (en) | 2006-11-13 | 2013-09-17 | Q-Core Medical Ltd. | Magnetically balanced finger-type peristaltic pump |
US20080129517A1 (en) * | 2006-11-24 | 2008-06-05 | Ventrassist Pty Ltd | Control System With Alarm |
US8167832B2 (en) | 2006-12-09 | 2012-05-01 | The Alfred E. Mann Foundation For Scientific Research | Ambulatory infusion devices and methods including occlusion monitoring |
EP1965325B1 (en) | 2007-03-01 | 2018-05-09 | BRACCO IMAGING S.p.A. | Therapeutic-diagnostic device |
KR101365088B1 (en) | 2007-05-04 | 2014-02-20 | 삼성디스플레이 주식회사 | Display panel and method for manufacturing the display panel |
JP2008293066A (en) | 2007-05-22 | 2008-12-04 | Panasonic Corp | Library for electronic circuit simulation, library generating system, recording medium storing them, and method for manufacturing electronic apparatus using them |
US8330579B2 (en) | 2007-07-05 | 2012-12-11 | Baxter International Inc. | Radio-frequency auto-identification system for dialysis systems |
FR2921443A1 (en) * | 2007-09-20 | 2009-03-27 | Fresenius Vial Soc Par Actions | FINGER LINEAR PERISTALTIC PUMP AND A MEMBRANE AND A FINGER FOR SUCH A PUMP |
MX2010007324A (en) | 2007-12-31 | 2010-09-30 | Deka Products Lp | Infusion pump assembly. |
US7867192B2 (en) | 2008-02-29 | 2011-01-11 | The Alfred E. Mann Foundation For Scientific Research | Ambulatory infusion devices and methods with blockage detection |
US9446185B2 (en) | 2008-03-12 | 2016-09-20 | Roche Diabetes Care, Inc. | Devices and methods for improving accuracy of fluid delivery |
KR101586513B1 (en) | 2008-04-01 | 2016-01-18 | 스미스 메디칼 에이에스디, 인크. | Software features for medical infusion pump |
US8133197B2 (en) * | 2008-05-02 | 2012-03-13 | Smiths Medical Asd, Inc. | Display for pump |
WO2009144726A1 (en) | 2008-05-29 | 2009-12-03 | Medingo Ltd. | A device, a system and a method for identification/authentication of parts of a medical device |
EP2158930B1 (en) | 2008-08-27 | 2017-06-28 | F. Hoffmann-La Roche AG | Flow control valves for leakage detection, free-flow prevention and occlusion detection |
US8378837B2 (en) | 2009-02-20 | 2013-02-19 | Hospira, Inc. | Occlusion detection system |
US8072764B2 (en) * | 2009-03-09 | 2011-12-06 | Apple Inc. | Multi-part substrate assemblies for low profile portable electronic devices |
US8591448B2 (en) | 2009-05-13 | 2013-11-26 | Haemonetics Corporation | Pressure monitoring within a fluid cassette |
US8547239B2 (en) | 2009-08-18 | 2013-10-01 | Cequr Sa | Methods for detecting failure states in a medicine delivery device |
KR101099915B1 (en) * | 2009-10-27 | 2011-12-28 | 엘에스산전 주식회사 | Reader based on rfid |
US8371832B2 (en) | 2009-12-22 | 2013-02-12 | Q-Core Medical Ltd. | Peristaltic pump with linear flow control |
US8394081B2 (en) | 2010-01-29 | 2013-03-12 | Kci Licensing, Inc. | Wound treatment apparatuses and methods for controlled delivery of fluids to a wound |
TW201200190A (en) * | 2010-03-26 | 2012-01-01 | Sanofi Aventis Deutschland | Electro-mechanical drug delivery device |
JP5715235B2 (en) * | 2010-04-01 | 2015-05-07 | ウー ヨン メディカル カンパニーリミテッド | Infusion device |
US8500673B2 (en) | 2010-04-20 | 2013-08-06 | Sorin Group Italia S.R.L. | Blood reservoir with level sensor |
US8734376B2 (en) | 2010-04-20 | 2014-05-27 | Sorin Group Italia S.R.L. | Perfusion system with RFID |
US8486020B2 (en) * | 2010-08-11 | 2013-07-16 | Zevex, Inc. | Pressure sensor and method of use |
JP2013538652A (en) | 2010-10-01 | 2013-10-17 | ゼヴェクス・インコーポレーテッド | Pressure sensor seal and usage |
GB2487040A (en) | 2010-11-09 | 2012-07-11 | Timothy Ottiwell Wykeham Waterfield | A linear peristaltic pump |
JP5720193B2 (en) * | 2010-11-16 | 2015-05-20 | ニプロ株式会社 | Infusion pump |
US9018893B2 (en) * | 2011-03-18 | 2015-04-28 | Medtronic Minimed, Inc. | Power control techniques for an electronic device |
US9220833B2 (en) * | 2011-06-27 | 2015-12-29 | Smiths Medical Asd, Inc. | Medicament infusion systems |
US8382703B1 (en) | 2011-10-18 | 2013-02-26 | King Saud University | Piezoelectric dual-syringe insulin pump |
US8603026B2 (en) | 2012-03-20 | 2013-12-10 | Medtronic Minimed, Inc. | Dynamic pulse-width modulation motor control and medical device incorporating same |
US8523803B1 (en) | 2012-03-20 | 2013-09-03 | Medtronic Minimed, Inc. | Motor health monitoring and medical device incorporating same |
US9463280B2 (en) | 2012-03-26 | 2016-10-11 | Medimop Medical Projects Ltd. | Motion activated septum puncturing drug delivery device |
GR20120100242A (en) | 2012-05-04 | 2014-01-02 | Micrel Ιατρικα Μηχανηματα Α.Ε., | Analgesia pump/pre-filled bag set |
US8888730B2 (en) | 2012-09-19 | 2014-11-18 | Sorin Group Italia S.R.L. | Perfusion system with RFID feature activation |
-
2014
- 2014-12-30 US US14/586,927 patent/US20150182697A1/en active Pending
- 2014-12-30 US US14/586,923 patent/US10232111B2/en active Active
- 2014-12-30 US US14/586,930 patent/US20150182698A1/en not_active Abandoned
- 2014-12-31 EP EP17203875.4A patent/EP3308811A1/en active Pending
- 2014-12-31 WO PCT/US2014/072964 patent/WO2015103377A2/en active Application Filing
- 2014-12-31 ES ES14827699.1T patent/ES2668987T3/en active Active
- 2014-12-31 JP JP2016543591A patent/JP6702873B2/en active Active
- 2014-12-31 BR BR112016015410A patent/BR112016015410A2/en active Search and Examination
- 2014-12-31 EP EP14827699.1A patent/EP3089772B1/en active Active
- 2014-12-31 CA CA2935686A patent/CA2935686A1/en not_active Abandoned
- 2014-12-31 AU AU2014373703A patent/AU2014373703B2/en active Active
-
2019
- 2019-01-09 US US16/243,662 patent/US20190143034A1/en active Pending
-
2020
- 2020-02-27 JP JP2020031258A patent/JP6922015B2/en active Active
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4529401A (en) * | 1982-01-11 | 1985-07-16 | Cardiac Pacemakers, Inc. | Ambulatory infusion pump having programmable parameters |
US4562751A (en) * | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US5368562A (en) * | 1993-07-30 | 1994-11-29 | Pharmacia Deltec, Inc. | Systems and methods for operating ambulatory medical devices such as drug delivery devices |
US5620312A (en) * | 1995-03-06 | 1997-04-15 | Sabratek Corporation | Infusion pump with dual-latching mechanism |
US6227203B1 (en) * | 1998-02-12 | 2001-05-08 | Medtronic, Inc. | Techniques for controlling abnormal involuntary movements by brain stimulation and drug infusion |
US20020193679A1 (en) * | 1998-04-29 | 2002-12-19 | Medtronic Minimed, Inc. | Communication station and software for interfacing with an infusion pump, analyte monitor, analyte meter, or the like |
US20020016568A1 (en) * | 2000-01-21 | 2002-02-07 | Lebel Ronald J. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US20050090808A1 (en) * | 2003-04-30 | 2005-04-28 | Luis Malave | Multi-processor medical device |
US20070214872A1 (en) * | 2006-02-14 | 2007-09-20 | Mettler-Toledo Ag | Measuring device, measuring probe, and method of operating the measuring device |
US20090067989A1 (en) * | 2007-09-06 | 2009-03-12 | M2 Medical Group Holdings, Inc. | Occlusion Sensing System for Infusion Pumps |
US20090099505A1 (en) * | 2007-10-12 | 2009-04-16 | Animas Corporation | Data Transmission System For A Drug Infusion Device |
US20110270219A1 (en) * | 2008-04-30 | 2011-11-03 | Roche Diagnostics International Ag | Administration device having a button with touch sensor |
US20110190852A1 (en) * | 2010-02-03 | 2011-08-04 | Dinsmoor David A | Implantable medical devices and systems having dual frequency inductive telemetry and recharge |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11020321B2 (en) * | 2014-10-15 | 2021-06-01 | Kpr U.S., Llc | Occlusion detection for flow control apparatus |
US11806502B2 (en) | 2015-11-20 | 2023-11-07 | Tandem Diabetes Care Switzerland Sarl | Micropump |
CN109562222A (en) * | 2016-08-12 | 2019-04-02 | 赛诺菲-安万特德国有限公司 | Drug delivery device |
US11311675B2 (en) | 2016-08-12 | 2022-04-26 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device |
US11529458B2 (en) | 2017-12-08 | 2022-12-20 | Amf Medical Sa | Drug delivery device |
US11813428B2 (en) | 2017-12-08 | 2023-11-14 | Tandem Diabetes Care Switzerland Sárl | Patch pump device for drug delivery |
WO2020002386A1 (en) * | 2018-06-29 | 2020-01-02 | Koninklijke Philips N.V. | Ironless electric motor for mri compatibility |
CN112335158A (en) * | 2018-06-29 | 2021-02-05 | 皇家飞利浦有限公司 | Ironless electric motor for MRI compatibility |
WO2021113057A1 (en) * | 2019-12-05 | 2021-06-10 | Hach Company | Peristaltic pump |
US11421672B2 (en) | 2019-12-05 | 2022-08-23 | Hach Company | Linear peristaltic pump with pinch and compression block arrangement |
US11241530B1 (en) * | 2020-11-23 | 2022-02-08 | Amf Medical Sa | Insulin patch pump having photoplethysmography module |
US11529464B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Systems and methods for monitoring delivery of microdoses of medication |
US11529461B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Initialization for systems and methods for delivering microdoses of medication |
US11529460B1 (en) | 2021-06-01 | 2022-12-20 | Amf Medical Sa | Systems and methods for delivering microdoses of medication |
US11541169B2 (en) | 2021-06-01 | 2023-01-03 | Amf Medical Sa | Applicators for systems and methods for delivering microdoses of medication |
US11679199B2 (en) | 2021-06-01 | 2023-06-20 | Amf Medical Sa | Systems and methods for delivering microdoses of medication |
US11712514B2 (en) | 2021-06-01 | 2023-08-01 | Tandem Diabetes Care Switzerland Sàrl | Cannulas for systems and methods for delivering microdoses of medication |
US11813382B2 (en) | 2021-06-01 | 2023-11-14 | Tandem Diabetes Care Switzerland Sàrl | Cannulas for systems and methods for delivering microdoses of medication |
US11857757B2 (en) | 2021-06-01 | 2024-01-02 | Tandem Diabetes Care Switzerland Sàrl | Systems and methods for delivering microdoses of medication |
Also Published As
Publication number | Publication date |
---|---|
JP6922015B2 (en) | 2021-08-18 |
US20150184648A1 (en) | 2015-07-02 |
JP2020110605A (en) | 2020-07-27 |
EP3089772B1 (en) | 2018-01-17 |
US20150182698A1 (en) | 2015-07-02 |
AU2014373703A1 (en) | 2016-07-28 |
WO2015103377A2 (en) | 2015-07-09 |
EP3308811A1 (en) | 2018-04-18 |
CA2935686A1 (en) | 2015-07-09 |
BR112016015410A2 (en) | 2017-08-08 |
AU2014373703B2 (en) | 2019-08-22 |
ES2668987T3 (en) | 2018-05-23 |
US10232111B2 (en) | 2019-03-19 |
US20190143034A1 (en) | 2019-05-16 |
EP3089772A2 (en) | 2016-11-09 |
JP2017500967A (en) | 2017-01-12 |
WO2015103377A3 (en) | 2015-08-27 |
JP6702873B2 (en) | 2020-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190143034A1 (en) | Pump, motor and assembly for beneficial agent delivery | |
US10141882B2 (en) | Motor health monitoring and medical device incorporating same | |
US9308321B2 (en) | Infusion device having gear assembly initialization | |
US10228663B2 (en) | Dynamic pulse-width modulation motor control and medical device incorporating same | |
US8603027B2 (en) | Occlusion detection using pulse-width modulation and medical device incorporating same | |
AU2014373708B2 (en) | Devices and methods for delivering a beneficial agent to a user | |
US4678408A (en) | Solenoid drive apparatus for an external infusion pump | |
US9433731B2 (en) | Detecting unintentional motor motion and infusion device incorporating same | |
JPS63272359A (en) | Drug injection apparatus | |
US20230043041A1 (en) | Syringe stiction break detection | |
US20230098831A1 (en) | Devices and methods for controlling electromechanical actuators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ABBVIE INC., ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ANDERSON, PHIL D.;CONJEEVARAM, RAJKUMAR;ZHOU, JI;AND OTHERS;SIGNING DATES FROM 20150626 TO 20150808;REEL/FRAME:036623/0674 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |